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  Malaria continues to be one of the most severe public health concerns worldwide. The 
malaria parasite, Plasmodium, is transmitted from person to person through the mosquito vector 
Anopheles. Vector control is a crucial element of anti-malarial campaigns and works best when 
there is thorough knowledge about an Anopheles vector’s biology and behavior in a given region. 
To fully eradicate malaria, new vector control strategies must be developed that exploit the 
behaviors of different vector species. One promising strategy to target vectors that primarily bite 
outdoors and display generalist feeding behaviors (zoophagic) is the use of veterinary systemic 
parasiticides. Veterinary parasiticides are drugs used in companion animals and livestock to kill 
endo- and/or ecto-parasites. By treating animals with systemic parasiticides, the mosquitoes 
feeding on these animals will be killed or sterilized, reducing the vector population and eliminate 
residual malaria transmission. 
The lethality and sublethal effects of seven veterinary systemic parasiticides (ivermectin, 
eprinomectin, moxidectin, abamectin, fipronil, fluralaner, and afoxolaner) were evaluated in two 
laboratory strains of zoophagic Anopheles vectors: Anopheles albimanus STECLA and An. 
stephensi STE2. One compound, ivermectin, evaluated for its effects on a wild population of An. 
albimanus (An. albimanus BELIZE). First, these compounds were fed to mosquitoes in vitro, 
using membrane feeders and mortality and reproductive capacities were examined. An. 
albimanus STECLA was highly tolerant of ivermectin (LC50 1468 ng/ml) and was most 
susceptible to fipronil (23 ng/ml). An. stephensi STE2 was most susceptible to ivermectin (LC50: 





An. albimanus STECLA (26.4 ng/ml). Ivermectin, fipronil, and afoxolaner significantly 
decreased reproductive capacity in treated An. stephensi STE2 and An. albimanus STECLA. 
In vivo tests using mice were also used to determine if systemic parasiticide vector 
control would be feasible in a live organism. Ivermectin reduced survival in both An. stephensi 
(χ2=87.1, p<0.0001) and An. albimanus (χ2=12.5, p=0.0004) that fed one day after mice were 
treated. Reproduction capacity also decreased in An. stephensi feeding on mice one day post 
treatment (t=8.18, p<0.0001). However, when fed three days after mouse treatment, only An. 
stephensi was still susceptible to ivermectin  (χ2=16.8, p<0.0001). Neither species had 
significantly reduced fecundity when fed on mice three days post treatment. Mice were also 
treated with either injectable or topical fipronil and mortality was quantified for mosquitoes 
feeding on the mice for up to 11 days post treatment. Fipronil significantly decreased survival in 
both species feeding on treated mice for up to 11 days post treatment. By day 11 post treatment, 
mortality decreased in both species feeding on mice injected with fipronil. By contrast, topically 
applied fipronil was still extremely toxic to both species.  
Ivermectin and fipronil were tested in cattle to determine if systemic parasiticides would 
work in a tropical environment. In Belize, three heifers were treated with topical fipronil, one 
cow was treated with an injectable form of ivermectin, and two left untreated. Mortality, blood 
meal digestion, and ovarian development were recorded for mosquitoes feeding 2-, 5-, 7- and 14- 
days post treatment. Both ivermectin and fipronil decreased survival in wild An. albimanus fed 
on the treated animals for up to 7 days post treatment. By day 14 post treatment, ivermectin was 
no longer lethal to mosquitoes. Fipronil was still signifcantly lethal to mosquitoes on day 14 post 
treatment, but the effect had waned. Both compounds reduced ovarian development in surviving 





To test how ivermectin distributes in the body and the effect of formulation on drug 
effectiveness, calves were treated with either a topical or injectable form of ivermectin. An. 
stephensi STE2 were fed on different body postions on calves and mortality, blood meal 
digestion, and ovarian development were recorded for 2, 5, 9, 14 and 23 days post treatment. 
Injectable and topical ivermectin both reduced survival until day 14, no matter where they fed on 
the body. Only mosquitoes fed on topically treated calves near the site of drug application 
experienced a reduction in survival. Mosquitoes fed on calves injected with ivermectin 
experienced a significant delay in blood meal digestion until after day 14 post treatment. 
Mosquitoes fed on calves treated with topical ivermectin experienced a significant delay in blood 
meal digestion until day 14 post treatment, and a slight delay in blood meal digestion on day 23 
post treatment. Ovarian development was also hindered in both treatments until day 14. On day 
23 post treatment, mosquitoes fed on calves injected with ivermectin had no significant delay in 
ovarian development, while those fed on calves treated with topical ivermectin still had a 
significant problem developing fully ovaries. 
Anopheles albimanus STECLA had the highest tolerance to ivermectin of any Anopheles 
species tested to date. To explore why, three possible mechanisms of resistance were examined. 
The first, midgut absorption was tested using parenteral injections of ivermetin. This bypassed 
the midgut and allowed ivermectin to directly interact with its target receptor. Ivermectin was 
significantly more toxic to An. albimanus STECLA when injected (LC50: 188 ng/ml) than when 
ingested (LC50: 1468 ng/ml). Next, an potential increase in cytochrome P450, an enzyme 
responsible for breaking down ivermectin, was tested by examining An. albimanus STECLA 
resistance to another compound broken down by cytochrome P450, permethrin. An. albimanus 





conformation changes in the target of ivermectin, the glutmate-gated chloride channels could be 
responsible for ivermectin tolerance. The sequences of several Aedes and Anopheles species 
were analyzed using phylogenetic methods to examine the glutamate-gated choride channel gene 
for selection. Seven exons were analyzed and an phylogenetic tree was constructed. The gene 
was highly conserved across the mosquito species, except on exon seven. While positive 
selection on this exon may influence ivermectin tolerance, it is not conclusive.  
In conclusion, veterinary systemic parasiticides are effective against two species of 
Anopheles mosquitoes. However, mosquitoes vary in their suceptibility to different compounds. 
Before implementing systemic parasiticides for vector control, local vector species must be 
evaluated for their susceptibility to the intended drug. The pilot trial provides proof-of-concept 
supporting this method of vector control. This study also is a cautionary tale that ivermectin 






Introduction and Objectives 
Malaria is one of the most severe public health concerns worldwide, with almost 230 
million cases and 400,000 deaths reported in 2018 [1]. Malarial symptoms including high fever, 
chills, muscle aches, and fatigue, are the result of intraerythrocytic infection by Plasmodium 
protozoan parasites. The parasites are transmitted from human to human by the bites of 
Anopheles mosquitoes. In recent years, there has been a global effort to not only reduce malarial 
transmission but eliminate and eventually eradicate the disease [2]. Malaria is caused by the 
Plasmodium protozoan and transmitted by Anopheles mosquitoes. Scale-ups in funding and 
manpower have led to improved public health, including affordable and effective medications, 
higher quality medical care, and increased efforts in the field of vector control [3]. Because of 
these efforts, the number of cases of malaria has decreased by 8% from 2010 to 2017 [2, 4, 5].  
Most of the global malarial burden is in Africa. However, in Central and South America, 
there are still approximately 1 million reported cases of malaria per year [2]. In 2018, the World 
Health Organization (WHO) established the Malaria Elimination Oversight Committee to work 
with countries projected to achieve malaria elimination by 2020 (E-2020) [2]. Of the 21 E-2020 
countries, 7 are in Central and South America, with one country (Paraguay) establishing 
complete elimination by 2018, as determined by WHO standards [2]. To accomplish elimination, 
conventional vector control and novel techniques will be needed to encompass the variation of 
mosquito feeding behaviors.  
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 Anopheles malarial vectors typically feed at night and on large mammals, but 
blood-feeding behavior often differs among species or even among populations within a 
species. There are three general categories that help define the relative impact a vector 
may have on malaria transmission [6, 7] 
1. Preferred blood source: Some species of Anopheles feed predominantly on humans 
(=anthropophagic behavior). Other species are more general in their feeding 
preferences, and are as likely to feed on livestock, domestic animals, etc. as they are 
on humans (=zoophagic behavior). In areas of high malaria transmission, 
anthropophagic behavior is of high importance since malaria is overwhelmingly 
transmitted by mosquitoes from one human host to the next. A high prevalence of 
malaria within a region is largely driven by one or more endemic anthropophagic 
vectors, while malaria prevalence is typically lower in areas with predominantly 
zoophagic vectors. 
2. “Hunting grounds”: Some malaria vectors are attracted and readily enter homes to 
obtain a blood meal (=endophagic behavior). Other Anopheles species prefer feeding 
outdoors (=exophagic behavior). 
3. Post-feeding resting: After a blood meal, mosquitoes must rest to process the blood 
meal. Among Anopheles exhibiting endophagic behavior, there are species and/or 
populations that will typically leave to digest their blood meals outside the dwelling 
(=exophilic behavior). Others prefer remaining indoors (=endophilic behavior), 
resting on walls, curtains, etc., until their blood meals are digested, after which they 






Understanding the behaviors of vector populations can be exploited to optimize specific 
malaria control strategies, even against a highly efficient vector species. For example, the 
distribution of insecticide-impregnated bed nets and conducting indoor spraying of long-lasting 
insecticides have been instrumental in reducing malarial transmission in several regions of Africa 
against the An. gambiae, a highly anthropophilic, endophagic, and endophilic vector [3, 8, 9]. In 
other areas of the world, such as Central and South America, malaria vectors, malaria vectors 
tend to be more zoophagic, exophagic, and exophilic in their behaviors [10–13]. Since malarial 
transmission occurs outdoors, insecticide-treated bed nets and indoor residual spraying are not as 
effective against mosquitoes exhibiting these behaviors. Although the distribution of bed nets has 
helped to reduce malarial transmission in the neotropics, they cannot by themselves eliminate 
transmission by endemic zoophagic, exophagic species. In these low transmission areas, 
alternative strategies will be needed to reduce the local vector populations below a level where 
transmission cannot be sustained.  
One strategy to reduce populations of zoophagic Anopheles is with the use of systemic 
veterinary parasiticides in livestock. The idea is by treating livestock with certain drugs, the 
mosquitoes that feed on treated livestock will be killed or sterilized. By reducing the vector 
population, livestock treatment could help eliminate residual malarial transmission by zoophagic 
Anopheles species. The strategy of using systemic parasiticides as a tool for malaria control is 
gaining acceptance within the malaria community, primarily because of the experimental work 
conducted with the most widely used and well known systemic parasiticide compound-
ivermectin.  
Ivermectin is a highly lipophilic drug that belongs to the macrocyclic lactone class of 





has been used for decades as an anti-helminthic in livestock [26, 27]. More recently, ivermectin 
has been administered to humans and has been instrumental in the fight to eradicate two 
devastating filarial nematode diseases, onchocerciasis (river blindness) and lymphatic filariasis 
(elephantiasis) [27]. More recently, the ingesting of relatively low doses of ivermectin has been 
shown to be lethal in several important African, Neotropical, and Indo-China malaria vector 
species [12-24].  
There are other macrocyclic lactones that may be more effective against different 
mosquito species or more appropriate for use, depending on the situation. For example, 
ivermectin cannot be used in lactating dairy cattle and ivermectin-treated beef cattle cannot be 
sold until 24-28 days after treatment [25]. The related compounds, eprinomectin and moxidectin, 
can be used in both dairy and beef cattle with no withdrawal period [Figure 1.1b, c; 25]. And one 
macrocyclic lactone, abamectin has been impregnated into beef cattle ear tags, releasing a small 
amount of the drug into the body for a long period of time, making it useful for treating and 
protecting beef cattle from parasites (in this case horn flies) over long periods of time [Figure 
1.1d; 46].  
The target of the macrocyclic lactones are the anionic glutamate-gated chloride channels 
(GluCl) found at neuro-muscular junctions. The GluCl receptors are members of the ligand-gated 
chloride channel family and are closely related to the glycine-gated channels in mammals [37]. 
Anionic GluCls are only found in invertebrate taxa [38]. Mammals do not have anionic 
glutamate-gated chloride channels, and the ivermectin molecule cannot readily cross the blood-
brain barrier to potentially bind to similar receptors, making the drug safe for use in mammals 





Chloride ions then flood into the synaptic cleft and inhibit action potential, causing paralysis and 
death [29]. 
Other systemic parasiticides and insecticides are also available that may be as effective or 
more effective than the avermectins. Fipronil, a phenylpyrazole, is a systemic insecticide 
commonly used against crop pests and in companion animals against fleas and ticks [Figure 1.1e; 
30]. There is a topical formulation approved for cattle use in several Central and South American 
countries (Ectonil®), but generally fipronil is not commonly used in cattle, due to a long 
withdrawal period for meat, and it cannot be used in lactating cattle [30]. However, it has long-
lasting residual effects and new formulations are in development that may shorten the 
withdrawal period [32, 33]. It has a different mode of action than the macrocyclic lactones and 
works by blocking gamma amino-butyric acid (GABA)-gated ion channels in arthropods, 
preventing the uptake of chloride ions, and causing uncontrolled nerve stimulation [30].  
Two newly developed products, fluralaner and afoxolaner are isoxazolines, systemic 
insecticides used to prevent fleas and ticks in companion animals and chickens [Figure 1.1f, g; 
35]. Like fipronil, these compounds are antagonists of the GABA-gated chloride channels, 
preventing the channels from opening and causing uncontrolled action potential [34, 35]. Further 
research into these drugs could lead to repurposing them for use in livestock and thus could be 
effective in reducing mosquito populations. While all these compounds work by interrupting the 
inhibitory nervous system, they act in opposite ways. The macrocyclic lactones are agonists, 
enhancing inhibitory neurotransmission and stopping action potential. Fipronil and isoxazolines 
are antagonists, blocking inhibitory neurotransmitters and causing unregulated hyperexcitability. 
The result is the same, paralysis and death of the organism. This knowledge can be exploited to 





The purpose of this project was to test the effects of seven systemic veterinary 
parasiticides on mosquito survival and reproductive ability. Central America was the target 
region to test this potential vector control strategy, due to the importance of livestock production, 
low malarial prevalence, and the abundance of endemic zoophagic Anopheles species in this 
region of the world. The focus species of my research was Anopheles (Nyssorhynchus) 
albimanus, a major vector along the coastal regions of Mexico, Central America, the Caribbean, 
and northern South America [35]. An important malaria vector in southern and western Asia, 
Anopheles (Cellia) stephensi, was also used as a comparison species [36]. Both species are 
highly zoophagic, exophilic and exophagic, making them appropriate species to target with a 
strategy involving veterinary systemic parasiticide treatment of livestock. Systemic veterinary 
parasiticides from the avermectin, phenylpyrazole, and isoxazoline families were tested using 
membrane feeds and live host feeds. Potential mechanisms of ivermectin resistance in the 












Figure 1.1. Chemical structures of the veterinary systemic parasiticides used during this research. A. Ivermectin; B. Eprinomectin; C. 
Moxidectin; D. Abamectin; E. Fipronil; F. Fluralaner; G. Afoxolaner. Diagrams from the National Center for Biotechnology 
Information PubChem repository [39-45] 
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DIFFERENTIAL SUSCEPTIBILITIES OF ANOPHELES ALBIMANUS AND 




Ivermectin has been a “wonder drug” against helminths and has demonstrated its lethality 
against several Anopheles species worldwide (Chapter 1). This study compared the relative 
toxicity of ivermectin to two known malaria vectors – Anopheles (Nyssorhynchus) albimanus, a 
neotropical malaria vector [1]; and Anopheles (Cellia) stephensi, an Asian malaria vector [2]. In 
this study, colony-reared An. stephensi STE2 and An. albimanus STECLA, and wild-caught An. 
albimanus from Belize (hereafter referred to as An. albimanus BELIZE) were used in membrane-
feeding experiments to test the lethality of ivermectin in different species and mosquito 
populations. An. albimanus STECLA and An. stephensi STE2 were also treated with sublethal 
ivermectin doses to examine the effects of ivermectin on fecundity. 
Materials and Methods 
Laboratory-reared Mosquitoes.  Laboratory colonies of Anopheles albimanus STECLA and 
An. stephensi STE2 strain were obtained as eggs through BEI Resources 
(https://www.beiresources.org/home.aspx).  Mosquitoes were reared in the University of North 
Dakota insectary at a photoperiod of 12-h light:12-h dark at 26°C.  Eggs were hatched in trays of 
dechlorinated water.  Larvae were fed fish food (Tetra Pond Sticks, Tetra, Blacksburg, VA) 
ground to a fine powder in an electric coffee grinder.  Pupae were placed into 28-liter wire mesh 
cages to emerge.  Adults were given access to water and a sugar source.  Female mosquitoes 3-7 
days post eclosion were aspirated from rearing cages into smaller (ca. 0.5 liter), cylindrical 
cardboard containers with mesh tops at a density of 15 to 40 mosquitoes per cage. 
Wild-caught Mosquitoes.  Host-seeking mosquitoes were collected during nighttime human 
landing catches in San Roman Rio Hondo, Orange Walk District, Belize. Mosquitoes were 





Belize. Anopheles albimanus mosquitoes were distinguished from other anopheline species 
routinely collected in San Roman (e.g., An. punctimacula, An. vestitipennis) based on the 
characteristic banding pattern on the hind tarsi of An. albimanus [3]. After identification, An. 
albimanus BELIZE were aspirated into smaller (ca. 0.5 liter) cylindrical plastic cages with mesh 
tops at a density of 15-30 mosquitoes. Mosquitoes were maintained at 26 °C with access to 8% 
honey solution ad libitum. 
Membrane Feeding (Lab-reared Mosquitoes).  For each membrane feeding trial, age-matched 
cohorts of An. albimanus STECLA and An. stephensi STE2 were blood-fed simultaneously on 
the same ivermectin preparations. Stock solutions were prepared fresh for each experiment. 
Ivermectin stock was prepared by diluting powdered technical grade ivermectin (Sigma-Aldrich, 
St. Louis MO, USA) into dimethyl sulfoxide (DMSO) at a concentration of 2 mg/ml.  The stock 
solution was then diluted to starting concentrations in phosphate-buffered saline (PBS), then 
serially diluted in 1.5 ml polypropylene microfuge tubes containing whole bovine blood with 
sodium heparin (10 U/ml, Pel-Freez Biologicals, Rodgers AR, USA) for a total volume of 1 ml.  
A control group (i.e., 10 µl PBS added to 990µl blood) was included with each trial.  Prior to 
feeding, the tubes were inverted to mix the solutions and kept in warm water.  Natural sausage 
casing (Dewied International, San Antonio TX, USA) was rinsed thoroughly to remove salt 
preservative and cut to fit across the bottom of glass membrane feeders.  Feeders were connected 
to one another with rubber tubing and heated water (ca. 37°C) was circulated to warm the 
feeders.  Membrane feeders were placed one per cage, and the blood-ivermectin mixtures were 
pipetted into the feeders.   Mosquitoes were allowed to feed for ca. 30 minutes.  Unfed 





cotton soaked in a 10% sucrose solution.  Cages were checked every day.  Dead mosquitoes were 
counted and removed.  After four days, the surviving mosquitoes were counted.   
Membrane Feeding (Wild-caught Mosquitoes).  Stock solutions of ivermectin (2 mg/ml into 
DMSO) were prepared at the University of North Dakota and transported to Belize. They were 
kept cool or frozen as much as possible. Ivermectin solutions diluted into water to starting 
concentrations of 20,000 ng/ml and 5000 ng/ml. The desired ivermectin concentrations were then 
made by adding human blood to a total volume of 8 ml (human blood was obtained from a local 
hospital blood bank.) The control group received blood with no additives. Prior to feeding, the 
tubes were inverted three times to mix the blood-ivermectin solutions and were kept in warm 
water. Natural ham collagen casing served as the membrane. The casing was soaked in distilled 
water and affixed to glass membrane feeders using a rubber band. Feeders were connected to one 
another with rubber tubing and a warm water bath circulated water (ca. 37°C) to warm the 
feeders.  Membrane feeders were placed one per cage, and the blood-ivermectin mixtures were 
pipetted into the feeders. Mosquitoes were allowed to feed up to 90 minutes in a dark room.  
Unfed mosquitoes were removed from the cages after feeding.  Engorged mosquitoes were 
maintained at 26 °C with access to 8% honey solution ad libitum. Cages were checked every day 
and the dead mosquitoes were counted and removed. After four days, the surviving mosquitoes 
were counted.  
Fecundity. Only laboratory strains of mosquitoes were used for fecundity studies. Mosquitoes 
were fed with membrane feeders on blood containing various doses of ivermectin, as described 
previously. An. stephensi STE2 mosquitoes were given a single experimental blood meal and 
monitored for egg production.  However, during colony rearing of An. albimanus STECLA, it 





eggs to maintain the colony.  To accurately assess the effect of ivermectin on An. albimanus 
STECLA fecundity, it was necessary that control-fed females undergo full gonotrophic 
development.  Therefore, An. albimanus STECLA were first given a normal blood meal (i.e., 
cow blood with no drugs).  Unfed mosquitoes were removed, and engorged mosquitoes were 
held for 2 days without oviposition sites.  The mosquitoes were then offered a second, 
experimental blood meal.  Unfed mosquitoes were removed.  One day after experimental blood 
meals, fully engorged mosquitoes were immobilized by chilling and each mosquito was placed 
into an individual 30ml glass vial with screened top and single strip of filter paper on which to 
rest.  Raisins were placed on top of each vial as a sucrose source.  After mosquitoes fully 
recovered and could fly, 2 ml of aged tap water was introduced into the vial for mosquitoes to 
lay their eggs.  Vials were maintained at 26°C for 120 hours, after which vials were filled with 
ethanol to kill the parent mosquito and the eggs and hatchlings.  Eggs and hatchling larvae were 
counted.  Midguts and ovaries from the parent mosquitoes were dissected to quantify blood 
digestion and ovarian development, based on the Sella scale [4].  For simplicity, Sella stages 
were combined into two groups: early stages (Sella stages II, III, IV) indicating that minimal 
vitellogenesis had occurred, and late stages (Sella stages V, VI, VII) indicating that complete or 
nearly complete vitellogenesis had occurred. 
Data Analysis.  Mosquito mortalities observed within experimental groups were adjusted for 
any mortality that occurred within corresponding control groups using Abbott’s formula [5].  
Only experimental trials having control mortalities less than 20% were used for further data 
analyses.  Log-probit analyses were conducted on the corrected percent moralities to estimate 
LC50 values (Minitab Inc., State College PA, USA).  Mosquito survivorship was analyzed with a 





USA).  Mosquito fecundity (i.e., average number of eggs laid per female) were compared among 
treatments using one-way analysis of variance (ANOVA) on log10 transformed egg counts.  If an 
ANOVA showed a significant effect due to treatment, the Tukey Honest Significant Differences 
(Tukey HSD) post hoc test was used to separate statistical differences between groups.  Rates of 
mosquito oviposition and egg hatching in treatment groups were compared with their 
corresponding controls with chi-square analyses (Statistix, Tallahassee FL, USA).  A 0.05 level 
of significance was used throughout. 
Results 
Membrane Feeding.  A total of 5 reps (573 An. stephensi STE2, 582 An. albimanus STECLA, 
and 352 An. albimanus BELIZE) were used to determine the relative oral toxicities of ingested 
ivermectin. Ingested ivermectin was much more toxic to An. stephensi STE2 (4-day LC50=7 
ng/ml) than to co-fed An. albimanus STECLA (4-day LC50=1468 ng/ml; Table 2.1). When 
ingested, ivermectin was more lethal to An. albimanus BELIZE compared to An. albimanus 
STECLA (4-day LC50=26.4 ng/ml; Table 2.1). Lethality of ingested ivermectin did not occur 
immediately. Instead, mosquito mortality progressed over a period of several days after ingestion 
of treated blood. Treated mosquitoes of all species and strains tested experienced significant 
reduction in survivorship over a 4-day period (Log-rank Mantel-Cox tests; An. stephensi STE2: 
χ2= 219.5, df=4, p<0.0001; colony-reared An. albimanus STECLA: χ2= 243.5, df=4, p<0.0001; 
An. albimanus BELIZE: χ2= 112.7, df=5, p<0.0001) (Figure 2.1).  Significant reductions of 
mosquito survival occurred with An. stephensi STE2 at all doses tested (4, 8, 16, and 32 ng 
IVM/ml; Figure 2.1a) and in all doses tested in An. albimanus BELIZE (25, 50, 150, 300, and 
1000 ng IVM/ml; Figure 2.1c) whereas with An. albimanus STECLA, significant reductions 





Fecundity.  The oviposition rate for control-fed An. stephensi STE2 after ingesting one blood 
meal (82%, n=38) was comparable to control-fed An. albimanus STECLA after ingesting two 
blood meals (84%, n=62) (Table 2.2).  Significant reductions in oviposition rates occurred in An. 
stephensi STE2 (33%, n=6) and An. albimanus STECLA (61%, n=51) that ingested ivermectin at 
32 and 1300 ng /ml respectively (Chi square tests, χ2>4.1, p<0.05) but not for mosquitoes that 
ingested lower concentrations of ivermectin (Table 2.2, Chi square tests, p>0.68).   
There were no differences in the average number of eggs laid per ovipositing female 
between control-fed and ivermectin-fed mosquitoes at any of the dosages tested for both An. 
stephensi STE2 (F= 0.45 df=4, 56; p=0.77) and An. albimanus STECLA (F= 1.33, df=2, 126; 
p=0.28) (Table 2.2).  However, the egg hatching rates for An. stephensi STE2 that ingested 8 
ng/ml ivermectin (56%, n=12) and An. albimanus STECLA that ingested 1300 ng/ml ivermectin 
(18%, n=51) were significantly less than egg hatch rates of the corresponding control-fed groups 
(73% and 48%, respectively) (Table 2.2, Chi square tests, χ2>43.1, p<0.05).  The egg hatch rate 
for An. stephensi STE2 that ingested 32 ng/ml ivermectin (52%) was lower than that of control-
fed mosquitoes, but the difference was not quite statistically significant (χ2=3.62, p=0.057).  This 
was likely due to the excessive adult mortality that occurred at this dose and the small number of 
surviving females (n=6) left to oviposit (Table 2.2).  Potential reductions in larva production in 
each treatment group were calculated by multiplying oviposition rates, fecundity and fertility for 
each treatment group (Table 2.2), and it was found that notable reductions in F1 larva production 
occurred only at doses that approached or exceeded the oral LC50 values for each species (Table 
2.1). There seemed to be a greater proportion of surviving mosquitoes found to have undigested 
blood in their guts and underdeveloped ovaries at early Sella stages with increasing ivermectin 






 Ivermectin ingested in a blood meal has been shown to be extremely potent, in both a 
laboratory setting and field experiments, against at least eight different anopheline species that 
have been tested to-date (Table 1).  In this study, I found ingested ivermectin be potent against 
An. stephensi STE2 and An. albimanus BELIZE at concentrations similar to other tested 
mosquito species (Table 2.1).  However, An. albimanus STECLA was found to be much less 
susceptible– over 25-fold less – than all other anopheline species tested to date. 
 Ingestion of ivermectin also reduced the reproductive potential of An. albimanus 
STECLA and An. stephensi STE2 by inhibiting blood meal digestion, vitellogenesis, oviposition 
rate, fecundity, and egg hatch of treated mosquitoes (Table 2.2).  However, statistically 
significant reductions in these reproductive parameters occurred only when mosquitoes ingested 
ivermectin that was at or exceeded the respective LC50 concentrations for each species. This is 
similar to what has been reported for ivermectin in An. arabiensis [6] but stands in contrast to 
results reported for An. aquasalis [10], where significant reductions in egg production and 
hatching were observed after mosquitoes had ingested ivermectin at a substantially lower 
potency – i.e., a concentration equivalent to the LC5 for that species (=18 ng/ml).  Defining the 
dose effects of ingested ivermectin on mosquito reproduction is important because significant net 
reductions in mosquito reproduction could still act to reduce mosquito populations, even if the 
dosage was not lethal. 
According to the recommendations of most commercial manufacturers of endectocide 
livestock products, a subcutaneous dose of ivermectin at 200 mg/kg BW is standard for control 
of intestinal nematodes.  At that dose and mode of delivery, the peak plasma concentrations of 





amount of ivermectin in the blood of treated cattle is enough to cause significant mortality and 
reproductive losses in several species of Anopheles mosquitoes that feed on treated animals, 
including An. gambiae [8], An. arabiensis [15, 16], An. culifacies and An. stephensi [17]. These 
experimental data suggest that plasma levels of ivermectin in this range would not cause 
mortality or loss of reproduction in An. albimanus STECLA that feed on ivermectin-treated 
cattle but would be sufficient to cause mortality in the Belizean An. albimanus. 
To successfully implement systemic parasiticides for vector control, it is essential to fill 
the gaps in the knowledge about how different mosquito species react to ivermectin and other 
compounds.  This study found wide differences in oral toxicities of ivermectin in An. stephensi 
STE2, An. albimanus STECLA, and An. albimanus BELIZE. These results have several 
important implications: 1.) Resistance to ivermectin is possible, as illustrated by An. albimanus 
STECLA), 2.) Wild specimens must be evaluated for their susceptibility to ivermectin, as they 
may differ greatly from that of mosquitoes reared in colony for numerous generations. Other 
compounds should be tested for their efficacy against these species to better tailor vector control 
to the local mosquito populations. Field studies are also crucial for identifying whether 
ivermectin or other veterinary systemic parasiticides would be candidates for vector control in 






Table 2.1.  Comparative toxicities of ivermectin to Anopheles mosquitoes when ingested in a 
blood meal via membrane feeders (oral LC50). All LC50 values are expressed as ng/ml. 
Subgenus Species 
Oral 4-day LC50  
(95% CL) 
Reference 
Cellia An. arabiensis 7.9 (6.2, 9.9) [6]  
 An. stephensi STE2 7.0 (5.2, 8.6) present study 
 An. minimus 16.3 (11.6, 19.4) [7]  
 An. gambiae s.l. 19.8 (+ 2.8) [8]  
 An. gambiae s.s. 22.4 (18.0, 26.9) [9]  
 An. campestris 26.4 (21.9, 30.5) [7]  
 An. sawadwongporni 26.9 (24.8, 28.8) [7]  
 An. dirus 55.6 (52.3, 59.1)  [7]  
Nyssorhynchus An. aquasalis 47.0 (44.7, 49.4)  [10] 
 An. albimanus STECLA 1,468.0 (1153.5, 1965.5) present study 
 An. albimanus BELIZE 26.4 (10.5, 45.3) present study 
 An. darlingi 43.2 (37.5, 48.6) [11]  
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Table 2.2.  Reproductive capacity of Anopheles mosquitoes ingesting various dosages of ivermectin via membrane feeder. Superscript 











Mean Number of Eggs 





of Larvae Produced 
per 1,000 Females 
An. stephensi  
STE2 
0 38 0.82A 9.2 (6.2, 13.7) A 0.73A 5530 
4 14 0.71A 11.5 (5.6, 23.5) A 0.70A 5724 
8 12 0.83A 12.6 (6.4, 24.8) A 0.56B 5867 
16 12 0.83A 8.6 (4.4, 17.0) A 0.76A 5425 
32 6 0.33B 1.3 (1.1, 22.4) A 0.52A 225 
An. albimanus 
STECLA  
0 62 0.84A 19.6 (15.1, 25.2) A 0.48A 7886 
300 53 0.87A 21.9 (16.7, 28.7) A 0.46A 8803 
1300 51 0.61B 27.6 (19.8, 38.4) A 0.18B 3098 
Anopheles stephensi mosquitoes were blood fed one time on either treated or untreated blood. Anopheles albimanus mosquitoes 
received an untreated blood meal, followed two days later by a second blood meal containing either treated or untreated (control) 
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Figure 2.1. Daily proportion of surviving mosquitoes after ingesting ivermectin at various 
concentrations. A. Anopheles stephensi STE2, B. Anopheles albimanus STECLA, C. Anopheles 






Figure 2.2. Proportions (95% CL) of An. stephensi STE2 and An. albimanus STECLA that either; completed vitellogensis and 
oviposited, underwent extensive vitellogenesis but did not oviposit (=late Sella), or underwent minimal vitellogenesis (=early Sella).  
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COMPARATIVE EFFECTS OF THREE CLASSES OF SYSTEMIC INSECTICIDES ON 








Previously, ivermectin was tested for its effects on lethality and sublethal effects on 
fecundity in An. albimanus STECLA and An. stephensi STE2. An. albimanus STECLA was the 
most ivermectin-resistant strain of Anopheles tested to date (Chapter 2; Table 2.1). While 
ivermectin is the most widely used veterinary systemic parasiticide, there are many other 
candidates that could be repurposed for livestock, and thus vector control (Chapter 1). 
I investigated the toxicity of six systemic parasiticides (eprinomectin, abamectin, 
moxidectin, fipronil, fluralaner, and afoxolaner; Figure 1.1) against An. stephensi STE2 and An. 
albimanus STECLA. Along with lethal effects, I also examined the effects certain compounds 
had on oviposition rate, the mean number of eggs per ovipositing female, and hatch rate of 
mosquitoes surviving a sublethal dosage of the drug.  
Materials and Methods 
Mosquitoes.  Laboratory colonies of An. albimanus STECLA strain and An. stephensi STE2 
strain were obtained as eggs through BEI Resources (Manassas, VA USA). Mosquitoes were 
reared in the University of North Dakota insectary at a photoperiod of 12-h light:12-h dark and a 
temperature of 22-26 °C. Eggs were hatched in trays of dechlorinated water. Larvae were fed 
fish food (Tetra Pond Sticks, Tetra, Blacksburg, VA USA) ground to a fine powder in an electric 
coffee grinder. Pupae were placed into ca. 28-liter wire mesh cages to emerge. Adults were given 
access to water and a sugar source, ad libitum. For membrane feeding, Female mosquitoes 2–12 
days old were aspirated from rearing cages into smaller (ca. 0.5 l), cylindrical cardboard 
containers with mesh tops at a density of 15–40 mosquitoes per cage. Mosquitoes were starved 





Membrane Feeding.  For each membrane feeding trial, age-matched cohorts of An. albimanus 
STECLA and An. stephensi were blood fed simultaneously using dilutions from the same stock 
solution. For each feeding trial, stock solutions were prepared fresh by diluting powdered the 
technical grade compounds (Sigma-Aldrich, Cayman Chemical, MuseChem) into dimethyl 
sulfoxide (DMSO) at a concentration of 2 mg/ml. The stock solution was diluted to starting 
concentrations in phosphate-buffered saline (PBS). From that, target concentrations were diluted 
in 1.5 ml polypropylene microfuge tubes containing whole bovine blood (10 U/ml, Pel-Freez 
Biologicals, L&M Meats INC) for a total volume of 1 ml. A control group (i.e., 10 µl PBS added 
to 990 µl blood) was included with each trial. Prior to feeding, the tubes were inverted a 
minimum of three times to mix the solutions and kept in warm water. Natural sausage casings in 
salt were rinsed thoroughly to remove salt preservative and cut to fit across the bottom of glass 
membrane feeders. Feeders were connected to one another with rubber tubing and heated water 
(ca. 37 °C) was circulated to warm the feeders. Membrane feeders were placed one per cage, and 
the blood-drug mixtures were pipetted into the feeders. Mosquitoes were allowed to feed for ca. 
30 min. Unfed mosquitoes were removed. Engorged mosquitoes were maintained in the insectary 
and provided with cotton soaked in a 10% sucrose solution. Cages were checked every day. 
Dead mosquitoes were counted and removed. For most trials, the number of surviving 
mosquitoes was counted at 4 days. This baseline mortality time was determined from previous 
work using ivermectin, where the rate of mortality had stabilized by 4 days [12]. After 
preliminary trials to determine an appropriate range of concentrations, feedings were replicated 2 
-5 times (approximately 200 to 450 mosquitoes per drug), plus a control, for each feeding trial. 
Fecundity.  Only fipronil, fluralaner, and afoxolaner were used for fecundity studies, as these 





were fed using glass membrane feeders containing various dosages of the target drugs as 
described previously. Dosages near or below the determined LC50 were used for each species. 
During colony rearing of An. albimanus STECLA, the species was noted to need additional 
blood meals to produce a sufficient quantity of eggs. Therefore, to assess the effect of these 
drugs on An. albimanus STECLA fecundity, the experimental mosquitoes received a normal 
blood meal with no drugs. Unfed mosquitoes were removed, and the engorged mosquitoes were 
held for 2 days with no oviposition sites. The mosquitoes then received the second, experimental 
blood meal and unfed mosquitoes were removed. The An. stephensi did not need additional 
blood meals to produce eggs and were only given the experimental blood meal and the unfed 
mosquitoes removed.  
Four days after the experimental blood meals, fully engorged mosquitoes were 
immobilized by chilling, and each mosquito was placed into an individual 30 ml glass vial with 
screened tops and a single piece of filter paper to rest. After mosquitoes recovered and were able 
to fly, 2 ml of aged tap water was introduced into the vials and a raisin was placed on top of the 
vial to provide sucrose. Vials were maintained at 21-26C for 3 days, after which they were filled 
with ethanol to kill the parent mosquito, eggs, and hatchlings. Eggs and larvae were counted the 
same day to determine the mean number of eggs laid and the hatch rate. 
Data analysis.  Mosquito mortalities observed within experimental groups were adjusted for any 
mortality that occurred within corresponding control groups using Abbott’s formula [1]. Only 
experimental trials having control mortalities less than 20% were used for further data analyses. 
Log-probit analyses were conducted to estimate LC50 values (Minitab Inc., State College PA, 
USA). Mosquito survivorship was analyzed with a Kaplan–Meier survival analysis and Log-rank 





normality (Sharpiro-Wilks test) and equal variances (Brown-Forsythe test). The treatments were 
compared using a one-way analysis of variance (ANOVA) and a Dunnett’s multiple comparisons 
test was performed to compare the experimental group means to the control group mean 
(GraphPad Software, La Jolla, CA, USA). Rates of mosquito oviposition were analyzed using 
Fishers exact test and egg hatch control and treatment groups were compared using a Chi square 
analyses (GraphPad Software, La Jolla, CA, USA). A 0.05 level of significance was used 
throughout. 
Results 
 The different endectocides and systemic insecticides varied in their effectiveness in both 
species. Eprinomectin was the most effective of the endectocides tested against An. stephensi, 
but it was not effective on An. albimanus (Table 3.1; Figure 3.1). Both abamectin and 
eprinomectin started to negatively affect An. stephensi survival at a lower concentration (50 
ng/ml), while it took a higher concentration (100 ng/ml) of moxidectin to become lethal to the 
mosquitoes (Figures 3.1-3.3). Abamectin was the most effective macrocyclic lactone against An. 
albimanus, but their LC50 was still very high (181 ng/ml) and would not fall within the levels 
seen in treated cattle (Table 3.1). Overall, the macrocyclic lactones were not as effective in An. 
albimanus compared to An. stephensi (Table 3.1. Figures 3.1-3.3). Fipronil was extremely 
effective against An. albimanus (Table 3.1. Figure 3.4b Fipronil was also effective against An. 
stephensi, though not as effective as seen in An. albimanus (Table 3.1. Figure 3.4a).  
Macrocyclic lactones and isoxazolines took longer (~2-3 days) to affect survivorship in both 
species (Figures 3.1-3.3, 3.5-3.6). Fipronil worked more quickly and only took 1-2 days to affect 
survivorship in both species (Figure 3.4). The most lethal drug tested against An. stephensi was 





 There was a significant reduction in oviposition rate in An. albimanus STECLA that 
ingested 25 ng/ml fipronil (Table 3.2, p=0.048). While not significant, there was also a decrease 
in An. stephensi oviposition rate (p=0.055). However, fipronil did not affect hatch rate or the 
number of eggs laid by the ovipositing females (Table 3.2)  
 Fluralaner slightly decreased the number of offspring produced by An. stephensi, but this 
was not significant (Table 3.3, p=0.068). There was not a decrease in offspring in An. albimanus 
STECLA treated with fluralaner (Table 3.3, p=0.606). There were no significant differences in 
the control or treated mosquito’s oviposition rate or hatch rate in either species (Table 3.3)  
 Afoxolaner significantly decreased An. stephensi oviposition rate but only at a dosage 
near their LC50 (Table 3.4). There was no significant different in oviposition rate in An. 
albimanus. However, both species experienced a significant decrease in the average offspring 
produced at the two highest dosages of afoxolaner compared to the control (Table 3.4; An. 
stephensi: 75 ng/ml: p=0.046, 100 ng/ml: 0.004; An. albimanus: 50 ng/ml: p=0.018, 75ng/ml: 
p=0.0003). Both species had a significant decrease in hatch rate when treated with afoxolaner 
compared to the control (Table 3.4).  
Discussion 
 While ivermectin is the most common used systemic insecticide and effective against a 
many Anopheles species, it may not be the best choice for all Anopheles. Previous research in 
these two species has found that, colony-reared An. stephensi and wild-caught An. albimanus are 
susceptible to ivermectin (LC50: 7 ng/ml and 26.4 ng/ml respectively), but colony-reared An. 
albimanus are highly resistant (LC50: 1468 ng/ml) [2]. Therefore, testing other compounds in 
Anopheles will allow vector control to be tailored to specific regions where vectors are not as 





This study found that the four compounds tested varied in effectiveness in two species of 
Anopheles. Other studies demonstrated the differences in effectiveness to the same compounds. 
Eprinomectin, when tested in An. gambiae [5] and An. arabiensis [3, 4], was found to have a 
similar LC50 to ivermectin. However, these data eprinomectin was almost 13 times less effective 
in An. stephensi (LC50: 88 ng/ml) compared to the LC50 of ivermectin in An. stephensi [2].  In 
An. albimanus, eprinomectin had almost no effect on survivorship, even at the highest dosages 
tested with an LC50 of over 10,000 ng/ml (Table 3.1). The major advantage that eprinomectin 
has over ivermectin is it can be used in lactating cattle without a withdrawal period [14].  
Moxidectin was also tested in An. gambiae and An. arabiensis and found to be the least 
effective macrocyclic lactone against these species [3, 5]. This was the case for An. stephensi 
(Table 3.1), though it was more susceptible to the drug than both An. gambiae (LC50: 2789 
ng/ml) and An. arabiensis (LC50: 1181 ng/ml) [3, 5]. Moxidectin did have a comparable toxicity 
in An. albimanus as was previously found in An. gambiae and An. arabiensis (Table 3.1) [3, 5].  
The last macrocyclic lactone tested was abamectin. Traditionally, abamectin is used as a 
miticide and anthelminthic for trees and crops [6], but it has also been shown to be effective 
against An. stephensi as a larvicide [7]. When administered to adult An. stephensi, abamectin was 
not as effective as ivermectin or eprinomectin (Table 3.1). Among the avermectins, it was the 
most effective macrocyclic lactone against An. albimanus, but the LC50 was still much higher 
than the plasma concentrations that would be found in a treated cow. Based on these results and 
when compared to the maximum plasma concentrations found in cattle, ivermectin is the only 
macrocyclic lactone that could be used successfully against An. stephensi or An. albimanus. 





that strains can drastically differ in their susceptibilities to certain compounds, as in the case of 
lab-reared and wild-caught An. albimanus (Chapter 2). 
 Fipronil is primarily used in agriculture and in companion animals to prevent fleas and 
ticks, though there are pour-on formulations used in Central and South America developed for 
livestock [8]. This compound was used to treat Zebu cattle in Kenya for vector control, and 
significantly reduced An. arabiensis survivorship when fed on the treated cattle [4]. The residual 
effects of the drug lasted for at least 21-days [4]. In this study, fipronil was effective against both 
species, but more effective against An. albimanus compared to An. stephensi (Table 3.1). While 
both LC50’s found in these two species are under the maximum plasma concentration in cattle, 
pharmacokinetics in cattle reveal that the maximum concentration rapidly declines to about 46 
ng/ml within 4 hours [9]. This length of time would be insufficient to effectively work against 
An. stephensi but would work against An. albimanus since this species has a much lower LC50. 
This study also demonstrates that fipronil decreases oviposition rates in dosages lower than the 
maximum concentration and, for An. albimanus, lower than the residual 46 ng/ml found in cattle 
after four hours (Table 3.2). The reduction in oviposition is an important finding; fipronil is long-
lasting and if both the lethal and adverse reproductive effects also linger, there would be a 
significant impact to the mosquito population and reduced malarial transmission. The effects of 
fipronil on mosquito reproduction are not known but has been studied in other arthropods. In 
Rhipicephalus sanguineus, fipronil affected the development on oocytes, damaging several vital 
cell structures such as the mitochondria and the plasma membrane [10]. While oviposition 
decreased, those that laid eggs produced normal amounts of eggs and the hatch rate was 
unaffected. Larval viability past the first instar was not examined, which may have revealed 





tenuiremis, had reduced egg extrusion when treated with fipronil [11]. Interestingly, there were 
also developmental delays in the resulting offspring, consistent with fipronil’s effect on tick 
reproduction. It remains to be seen if fipronil would similarly affect larval development in 
mosquitoes, even if egg production and hatch rate are unchanged.   
 Afoxolaner and fluralaner are currently only available for companion animals and 
chickens. However, Miglianico et al. demonstrated that both fluralaner and afoxolaner were 
effective against several mosquito species, including An. stephensi [12]. This study showed An. 
stephensi was more resistant to fluralaner and afoxolaner than the previous study, but this may be 
due to strain differences. Conversely, An. albimanus was more susceptible to both afoxolaner 
and fluralaner compared to An. stephensi, though both species were less susceptible to 
afoxolaner than to fluralaner (Table 3.1). There were no significant differences in fertility or 
fecundity when either species was treated with fluralaner (Table 3.3). However, when treated 
with afoxolaner, both species experienced a significant reduction in offspring compared to the 
control group (Table 3.4). Hatch rate was also significantly affected in both species (Table 3.3). 
While there was no difference in the oviposition rate in treated An. albimanus, the oviposition 
rate was significantly reduced in An. stephensi treated near the LC50 (Table 3.3). These 
reductions in fecundity are incredibly important, as it will increase the odds of reducing the 
mosquito populations to a point where the parasite cannot sustain itself and interrupting malarial 
transmission. Like fipronil, there is no research on the effects of isoxazolines on mosquito 
reproduction. In fleas, however, afoxolaner does affect reproduction, with research showing that 
the population structure of fleas captured from dogs/homes treated with afoxolaner were more 
predominantly male than female, a metric used by those in flea control to determine if 





drug concentrations would be in treated cattle, but the use of isoxazolines in livestock for vector 
control should be further investigated, as these compounds are lethal and have sublethal effects 
on reproduction. Also, having more compounds available for use can decrease the likelihood of 
mosquitoes developing resistances to the drugs if their use is rotated periodically.  
 To implement successful vector control measures using veterinary systemic parasiticides, 
various compounds must be tested as mosquitoes vary in their susceptibility to different 
compounds. Ivermectin is still the best choice of systemic parasiticide against An. stephensi, but 
these experiments show fipronil is more effective against An. albimanus than ivermectin. Also, 
the sublethal effects certain drugs have on the mosquitoes should not be discounted but can 
provide a valuable tool to reduce mosquito populations. Having a variety of compounds will not 
only ensure that vector control is tailored to a specific region/species, but also reduce the 
probability of resistance. As these experiments were all conducted in vitro, the next step is in 
vivo testing. After all, if the compound is effective in vitro but not in vivo, implementing 





Table 3.1. Comparative toxicities of ingested insecticides in An. stephensi and An. albimanus and the maximum concentration of each 
drug in cattle plasma. LC50 values expressed as ng/ml. 
Compound An. stephensi LC50 (95% CL) 
Replicates 
(N) 





concentration in cattle (ng/ml) 
Ivermectin* 7.0 (5.2, 8.6) 5 (573) 1468.0 (1153.5, 1965.5) 5 (582)  
Eprinomectin 88.0 (70.1, 111.6) 5 (453) >10,000 3 (273) 44.0 (subcutaneous injection; Holstein cattle) [14] 
Abamectin 155.2 (115.4, 214.0) 4 (444) 181.4 (128.6, 246.8) 2 (227) 25.4 (subcutaneous injection; Angus cattle) [15] 
Moxidectin 263.9 (194.1, 356.8) 4 (376) 1267.1 (767.7, 2944.4) 2 (342) 39.4 (subcutaneous injection; Hereford cattle) [16]  
Fipronil 122.8 (101.1, 150.2) 4 (425) 23.5 (19.5, 28.0) 3 (310) 378.1 (subcutaneous injection; Zebu cattle) [9] 
Fluralaner  99.9 (83.0, 120.3) 3 (231) 32.0 (23.5, 43.5) 3 (188) 3948 (oral; Beagle dogs**) [17] 
Afoxolaner 96.4 (76.6, 121.2) 3 (357) 73.0 (62.2, 85.0) 3 (301) 1655 (oral; Beagle dogs**) [18] 
*Determined in Chapter 2. 






Figure 3.1. Daily proportion of surviving mosquitoes after ingesting eprinomectin at various 







Figure 3.2. Daily proportion of surviving mosquitoes after ingesting abamectin at various 







Figure 3.3. Daily proportion of surviving mosquitoes after ingesting moxidectin at various 







Figure 3.4. Daily proportion of surviving mosquitoes after ingesting fipronil at various 







Figure 3.3. Daily proportion of surviving mosquitoes after ingesting fluralaner at various 
concentrations. A. Anopheles stephensi, B. Anopheles albimanus. 






Figure 3.3. Daily proportion of surviving mosquitoes after ingesting afoxolaner at various 





Table 3.2. Fipronil.  Fecundity of Anopheles mosquitoes ingesting and surviving sub-lethal concentrations of drug. Superscripts 










Geometric mean no. of eggs 




Theoretical number of larvae 




0 39 0.59A 56.3 (47.0, 67.5) A 0.36A 13735 (10422, 17048) A 
50 39 0.59A 46.7 (35.6, 61.1) A 0.35A 11184 (8763, 13605) A 
150 30 0.40A 46.1 (35.1, 60.7) A 0.39A 7232 (4740, 9723) B 
An. albimanus  
(23 ng/ml) 
0 64 0.59A 36.4 (32.1, 41.3) A 0.32A 7455 (5965, 8945) A 
10 33 0.52A 36.9 (29.0, 46.9) A 0.30A 6362 (4381, 8344) A 
25 41 0.39B 28.9 (20.0, 41.6) A 0.33A 4436 (2419, 6454) B 
An. stephensi mosquitoes received a single blood meal, containing either treated or untreated (control) blood. An. albimanus 
mosquitoes received two blood meals: an untreated blood meal, followed two days later by a second meal of either treated or untreated 
(control) blood. Engorged mosquitoes were first held together in small containers for four days, then individually held in oviposition 





Table 3.3. Fluralaner.  Fecundity of Anopheles mosquitoes ingesting and surviving sub-lethal concentrations of drug. Superscripts 










Geometric mean no. of 




Theoretical number of 
larvae produced per 




0 19 0.63A 58.1 (51.1, 66.1) A 0.60A 22713 (17142, 28284) A 
25 29 0.81A 63.0 (52.7, 75.3) A 0.59A 32651 (24972, 40331) A 
75 15 0.83A 45.0 (31.4, 64.7) A 0.60A 26117 (15810, 36424) A 
An. albimanus 
(32 ng/ml) 
0 29 0.52A 32.3 (23.8, 43.7) A 0.37A 7072 (3778, 10366) A 
10 25 0.48A 39.5 (31.6, 49.2) A 0.42A 6800 (3922, 9678) A 





Table 3.4. Afoxolaner. Fecundity of Anopheles mosquitoes ingesting and surviving sub-lethal concentrations of drug. Superscripts 










Geometric mean no. 






Theoretical number of 
larvae produced per 




0 93 0.72A 85.3 (78.3, 92.9) A 0.67A 43372 (38325, 48419) A 
25 26 0.77A 77.6 (62.8, 95.9) A 0.61B 39848 (27235, 52460) A 
75 18 0.72A 60.2 (43.9, 82.6) B 0.63B 30462 (15788, 45135) A 
100 38 0.40B 47.0 (29.6, 74.8) B 0.38B 9173 (3940, 14406) B 
An. albimanus 
(73 ng/ml) 
0 73 0.55A 82.5 (70.4, 90.0) A 0.47A 21533 (16406, 26659) A 
10 23 0.43A 67.8 (55.7, 82.7) A 0.18B 5332 (1500, 9164) B 
25 22 0.45A 64.5 (57.8, 72.0) B 0.21B 6030 (1681, 10379) B 
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LETHALITY OF IVERMECTIN AND FIPRONIL IN TWO SPECIES OF ANOPHELES 







Membrane feedings demonstrated ivermectin and fipronil were the most effective 
veterinary systemic parasiticides against An. stephensi and An. albimanus respectively (Chapter 
2, Chapter 3). However, drug toxicity and effects can vary in live hosts compared to what is 
observed in vitro, due to metabolism and other physiological reactions within the body. 
Therefore, it is necessary to perform in vivo testing of these drugs before implementing any 
wide-scale vector control. To test if these two compounds would be as effective on the 
mosquitoes when fed on a live organism versus a membrane feeder, I fed An. stephensi and An. 
albimanus on mice treated with ivermectin and fipronil to examine the lethality of the drugs. As 
ivermectin has sterilizing effects on Anopheles [1-3], oviposition and hatch rate were also 
examined in ivermectin-treated mosquitoes.  
Materials and Methods 
Mosquito rearing.  Laboratory colonies of Anopheles albimanus STECLA and Anopheles 
stephensi STE2 strains were obtained as eggs from BEI Resources (Manassas, VA USA). 
Mosquitoes were reared in the University of North Dakota insectary at a photoperiod of 12-h 
light:12-h dark and a temperature of ~26 °C. Eggs were hatched in trays of dechlorinated water. 
Larvae were fed fish food (Tetra Pond Sticks, Tetra, Blacksburg, VA USA) ground to a fine 
powder in an electric coffee grinder. Pupae were placed into ca. 28 l wire mesh cages to emerge. 
Adults were given access to water and a sugar source. Female mosquitoes 4-12 days old were 
aspirated from rearing cages into smaller (ca. 0.5 l), cylindrical cardboard containers with mesh 
tops at a density of 10-20 mosquitoes per cage. New mosquitoes were aspirated into new cages 





Ivermectin treatment and feeding.  Ivermectin stock solution (2000 µg/ml DMSO) was diluted 
in saline to a working concentration of 80 µg/ml.  Three mice were weighed and subcutaneously 
injected with an appropriate volume of ivermectin solution to achieve a dose of 0.6 µg/gm BW.  
Three control mice were injected subcutaneously with equivalent volumes of saline.  The next day 
(=24h after treatment), each mouse was anesthetized (pentobarbital 60 µg/gm BW, i.p.) and 
individually placed onto a screened-top cage containing 20 to 30 An. albimanus mosquitoes.  
Mosquitoes were allowed to feed for ca. 20 minutes, after which anesthetized mice were 
immediately transferred to screen-top containers containing 20 to 30 An. stephensi mosquitoes.  
Mosquitoes were allowed ca. 30 minutes to feed. Mice were then returned to their cages. Any 
unfed mosquitoes were removed from the cages.  Engorged mosquitoes were provided with a 
sucrose and water source and maintained at 26°C and high humidity.  Four days after blood 
feeding, mosquitoes were provided a cup of water for oviposition.  This process was repeated three 
days later (72h after treatment), using fresh batches of An. albimanus and An. stephensi 
mosquitoes.  All mosquito cages were checked daily for a total of 6 days after each blood-feeding, 
dead mosquitoes were removed and counted, and at the end of 6 days the number of mosquitoes 
left alive, as well as the number of eggs laid, were counted.   
Fipronil treatment and feeding.  Injectable fipronil dosage was determined based the previous 
ivermectin experiment (0.6 µg/gm BW) 6 mg of technical grade fipronil (Sigma-Aldrich) was 
dissolved in 3 ml of dimethyl sulfoxide (DMSO) to make a stock solution. To make a working 
dilution, 100 µl of the fipronil stock solution was diluted in 1.25 ml of sterile minimum essential 
medium (MEM). Each mouse was then injected subcutaneously into the shoulder region with the 
appropriate volume of working fipronil solution. A commercial fipronil product (PetArmor®, 





ml per cat) was equilibrated for mice (11 µl per 20 gm mouse). To apply the topical fipronil, it 
was first placed on a clean microscope slide. This allowed the fipronil to easily be pipetted. The 
application site of each mouse was cleaned with 70% ethanol and allowed to dry before 
application. The fur was parted using a clean tissue and the topical fipronil was applied. Three 
mice were assigned to each treatment group: control, injectable fipronil, and topical fipronil. One 
mouse in the topical application group died during the experiment, leaving two mice in that 
treatment group.   
Mice were anesthetized prior to mosquito feeds using a 100 mg/ml ketamine/ 20 mg/ml 
xylazine solution (0.1 ml per 10 g body weight, interperitoneally) and given 5 minutes for the 
drug to act. The mice were then individually placed onto the screened top containers with 10-20 
female An. stephensi mosquitoes. Mosquitoes were allowed to feed for ~20 minutes or until the 
majority were fully engorged. This was then repeated with the same mice with containers of An. 
albimanus. The mice were returned to their cages after the feedings. Unfed females were 
aspirated out of the cages and the cages were given a cotton pad soaked in 10% sucrose solution 
for food and hydration. Dead mosquitoes were recorded and removed from the cages every day 
for 5 days post-feed. The mosquito feedings occurred 2-, 4-, 7-, and 11-days post fipronil 
treatment to observe the drug’s residual effects.  
Data analysis.  Survivorship curves and median survival times were constructed and analyzed 
using a Kaplan–Meier survival analysis and Log-rank Mantel-Cox test (GraphPad Software, La 
Jolla, CA, USA). Treatment effectiveness was analyzed using chi-square analysis to compare 
treatments to one another and to the control (GraphPad Software, La Jolla, CA, USA).  Rates of 





corresponding controls with chi-square analyses (Statistix, Tallahassee FL, USA).  A 0.05 level 
of significance was used throughout. 
Results 
Ivermectin. One day after injections, there were significant reductions in the 6-day survival rate 
of An. stephensi (15%) and An. albimanus (56%) that fed on ivermectin-treated mice compared to 
mosquitoes fed on control mice (100% and 89%, respectively, Chi square tests with Yate’s 
correction, χ2>11, p<0.001; Table 4.1; Figure 4.1a, c).  Average fecundity in An. stephensi fed on 
ivermectin-treated mice (0.9 + 1.6 eggs/female) was significantly less than mosquitoes fed on 
control mice (46.1 + 25.9 eggs/female) (t-test, t=8.2, df=13, p<0.0001).  No significant reduction 
in fecundity was observed for An. albimanus fed on ivermectin-treated mice.  Three days after 
mice were treated with ivermectin, there remained a significant, albeit smaller, reduction in the 6-
day survival of An. stephensi fed on ivermectin-treated mice (62%) versus that of An. stephensi 
fed on control mice (96%) (Chi square tests with Yate’s correction, value=8, p<0.001; Table 4.1, 
Figure 4.1b).  No significant difference was observed in the 6-day survival of An. albimanus due 
to mouse treatment (Figure 4.1d).  By three days after mouse injections, there were no significant 
differences in mosquito fecundity for either species fed on ivermectin-treated versus control mice 
(Table 3). 
Fipronil. On Day 2, the Anopheles stephensi fed poorly, leading to high variation in survival in 
both fipronil treatment groups. However, there was still a reduction in survival in the treatment 
groups compared to the control on day 2 (topical: 33%, injectable: 30%, control: 100%).  Both 
formulations were toxic to An. stephensi, even up to day 11 post-treatment (Table 4.2). Except 





injectable fipronil (Figure 4.2., Table 4.2). Topical fipronil also worked more quickly against An. 
stephensi than injectable fipronil on Days 4, 7, and 11, with a median survival of 1 day for 
topical fipronil and a minimum median survival time of 2 days after feeding for injectable 
fipronil (Figure 4.2b-d, Table 4.2). Injectable fipronil was lethal to An. stephensi but its 
effectiveness began to wane while topical fipronil was still potent to the treated mosquitoes 
through day 11 (Figure 4.2d, Table 4.2). This is evident not only in the percent survival on day 
11, but in the median survival time, which was still 1 day after feeding for topically treated An. 
stephensi (Table 4.2). By day 11 post treatment, there was no difference in median survival time 
for An. stephensi. 
Compared to An. stephensi, An. albimanus was more susceptible to fipronil, no matter the 
formulation (Figure 4.3, Table 4.3). As with An. stephensi, topical fipronil worked faster on An. 
albimanus, and had a median survival time of 1 day throughout the experiment (Table 4.3). 
However, injected fipronil also had a median survival time of 1 day through much of the 
experiment, only increasing after day 11 post treatment (Table 4.3). By day 7 and day 11 post 
treatment, the injected fipronil began wearing off, while topically applied fipronil was still potent 
(Figure 4.3c, Figure 4.3d). Notably, at day 11 post treatment, survival slightly increased in An. 
albimanus that fed on topically treated mice, while their An. stephensi counterparts had no 
survivors at this time point.  
Discussion 
 Ivermectin has been shown to be effective against several species and strains of 
Anopheles around the world, including Anopheles stephensi [1-16]. However, the laboratory 
strain An. albimanus STECLA is highly tolerant of ivermectin [1]. In this in vivo experiment, An. 





significant decreases in survival when fed on ivermectin treated mice one day after treatment. 
Three days post treatment, An. stephensi was still susceptible to ivermectin, while An. albimanus 
had no significant differences in survival compared to the controls (Table 4.1).  
Only An. stephensi had a significant reduction in egg production after the ivermectin 
treatment, and only after feeding one day post treatment (Table 4.1). Other studies demonstrate 
ivermectin can reduce fecundity in treated mosquitoes as well. However, in cattle, ivermectin’s 
sterilizing effects lasted much longer, up to 17 days post treatment compared to mosquitoes 
feeding on mice one day post treatment with ivermectin [2]. This discrepancy can be explained 
by the differences in metabolism between cattle and mice, with mice having less body fat to trap 
and slowly release ivermectin over time and an overall faster metabolism than cattle.  
 Fipronil may be a compound that can be implemented into livestock management to 
supplement ivermectin treatment. While it is not commonly used in cattle, a formulation for 
sheep and cattle has been developed and approved for use in several South and Central American 
countries (Ectonil®, Agrovetmarket, Lima PERU). In a previous study, an experimental 
injectable form of fipronil was shown to be long-lasting in cattle and effective at reducing the 
number of Rhipicephalus microplus on the cattle, over 23 days after the treatment [20]. These 
results show that, though not as effective against An. stephensi, fipronil was extremely effective 
in An. albimanus compared to the control (Table 4.2, 4.3) Also, topically applied fipronil 
remained toxic to treated mosquitoes 11 days post treatment (Table 4.2, 4.3). In cattle, an oral 
form of the drug demonstrated lethality against An. arabiensis up to 14 days post treatment [11], 
comparable to the results of this experiment. 
 Testing these compounds in vivo is essential in developing vector control through 





affects the effectiveness of the drug. The results of this experiment confirmed the results from in 
vitro studies: An. stephensi is highly susceptible to ivermectin, while An. albimanus STECLA is 
highly susceptible to fipronil. The next step is implementing fipronil and ivermectin in a field 
study using cattle and wild An. albimanus. As discovered in previous research, the wild An. 
albimanus are much more susceptible to ivermectin than their lab complements. It is not known 
if fipronil will affect the wild mosquitoes the same as lab-reared mosquitoes. Therefore, the 
outcome of the cattle trials and the use of wild mosquitoes will be essential to determine if 







Table 4.1. Ivermectin. Survival and fecundity of Anopheles stephensi and Anopheles albimanus mosquitoes 6 days after blood-feeding 
on mice that had received a single subcutaneous injection of either ivermectin (0.6 µg/gm BW) or saline (control group).  Three mice 
were used for each treatment.  Cohorts of age-matched mosquitoes were blood-fed one day after injections and three days after injections.   
  One day after mouse injections Three days after mouse injections 
Species Treatment Percent Surviving (n) Eggs per female (+SD) 
Percent Surviving 
(n) 
Eggs per female (+SD) 
An. stephensi 




62% (66) χ2=16.8 
p<0.0001 
30.8+8.7 t=1.00 
p=0.373 Control 100% (56) 46.1+25.9 96% (48) 44.7+18.8 
An. albimanus 




95% (57) χ2=0.94 
p=0.332 
25.2+7.2 t=0.18 






Table 4.2. Fipronil. Percent survival (number mosquitoes) and median survival (days) of Anopheles stephensi for five days after 
feeding on mice either receiving no treatment, injectable (0.6 µg/g BW) or topical fipronil (53 µg/g BW). New mosquitoes were fed 
on the mice at various time points after the initial treatment.   
Treatment Number of mice Percent mosquito survival (n); median survival in days 
  2 days post treatment 4 days post treatment 7 days post treatment 11 days post treatment 
Control 3 100% (3); >5 days* 98% (37); >5 days* 97% (44); >5 days* 100% (32); >5 days* 
Topical 2 33% (6); 1 day 0% (27); 1 day 0% (27); 1 day 0% (26); 1 day 
Injectable 3 30% (29); 3 days 47% (39); >5 days* 34% (33); 2 days 58% (36); >5 days* 
Statistical Comparisons Between Survival Rates 
Control vs. Topical χ2 = 3.2, p = 0.074 χ2 = 63, p < 0.0001 χ2 = 70, p < 0.0001 χ2 = 57, p < 0.0001 
Control vs. Injectable χ2 = 4.16, p = 0.041 χ2 = 22.3, p < 0.0001 χ2 = 26.3, p < 0.0001 χ2 = 18.4, p = 0.029 
Topical vs. Injectable χ2 = 0.46, p = 0.467 χ2 = 65, p < 0.0001 χ2 = 39.5, p < 0.0001 χ2 = 57.1, p < 0.0001 






Table 4.3. Fipronil Percent survival (number mosquitoes) and median survival (days) of Anopheles albimanus for five days after 
feeding on mice either receiving no treatment, injectable (0.6 µg/gm BW) or topical fipronil (53 ug/g BW). New mosquitoes were fed 
on the mice at various time points after the initial treatment.   
Treatment Number of mice Percent mosquito survival (n); median survival in days 
  2 days post treatment 4 days post treatment 7 days post treatment 11 days post treatment 
Control 3 96% (20); >5 days* 100% (27); >5 days* 97% (35); >5 days* 86% (22); >5 days* 
Topical 2 0% (4); 1 day 0% (19); 1 day 0% (19); 1 day 6% (22); 1 day 
Injectable 3 0% (28); 1 day 0% (21); 1 day 11% (23); 1 day 54% (31); >5 days* 
Statistical Comparisons Between Survival Rates 
Control vs. Topical χ2 = 23, p < 0.0001 χ2 = 45, p < 0.0001 χ2 = 53, p < 0.0001 χ2 = 25.3, p < 0.0001 
Control vs. Injectable χ2 = 49.4, p < 0.0001 χ2 = 49.1, p < 0.0001 χ2 = 59.8, p < 0.0001 χ2 = 4.8, p = 0.029 
Topical vs. Injectable χ2 = 0.458, p = 0.500 χ2 = 7.1, p = 0.008 χ2 = 6.8, p = 0.009 χ2 = 26.5, p < 0.0001 






Figure 4.1. Ivermectin. Daily proportion of surviving mosquitoes after feeding on ivermectin treated mice 1 and 3 days after 
treatment. A. An. stephensi fed 1 day after mouse treatment, B. An. stephensi fed 3 days after mouse treatment C. An. albimanus fed 1 






Figure 4.2. Daily proportion of surviving An. stephensi after feeding on mice treated with either topical or subcutaneous injection of 







Figure 4.3. Daily proportion of surviving An. albimanus after feeding on mice treated with either topical or subcutaneous injection of 
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FIPRONIL AND IVERMECTIN TREATMENT OF CATTLE TO REDUCE SURVIVAL 







 Fipronil was the most effective systemic parasiticide tested against Anopheles albimanus 
both in vitro (through membrane feeding) and in vivo (in mice) (Chapters 2-4). The goal of this 
pilot study was to evaluate survivorship of wild-caught An. albimanus, a dominant Central 
American malaria vector, after feeding on fipronil- and ivermectin-treated cattle in Orange Walk 
District in North-Central Belize. The residual activity and potential sub-lethal effects of the 
treatments on mosquito blood meal digestion and ovarian development were also examined. 
Materials and Methods 
Mosquitoes.  Host-seeking mosquitoes were collected at night by human landing catches in San 
Roman Rio Hondo, Orange Walk District, Belize.   Mosquitoes were transported to the Belize 
Vector and Ecology Center (BVEC) laboratory in Orange Walk Town, Belize.  Anopheles 
albimanus mosquitoes were distinguished from other anopheline species routinely collected in 
San Roman (e.g., An. punctimacula, An. vestitipennis) based on the characteristic banding pattern 
on the hind tarsi of An. albimanus [1].  Mosquitoes were maintained at 26C with access to 8% 
honey solution ad libitum.  Mosquito collections were conducted for two consecutive nights prior 
to each cattle feed.  To estimate potential changes in the age structure of the mosquitoes used 
during the experiment, all mosquitoes that had not blood-fed at the conclusion of a particular 
feeding trial were dissected and scored as either nulliparous or parous, based on the presence 
(=nulliparous) or absence (=parous) of tracheolar coiling or skeins on the surface of the ovaries 
[23-25].  Parity rate was expressed as the percentage of parous mosquitoes.  
Cattle Treatment and Mosquito Feeds.  The experiment was conducted on a cattle ranch near 
the village of San Felipe, Orange Walk District, Belize, with the informed consent of the ranch 





ranging from 315 to 430 kg, were selected for use.  Cattle had not received insecticidal or 
acaricidal treatment for at least 6 months prior to initiating the experiment.  There were two 
treatment groups and one control group. Three heifers received Ectonil® Pour-on (1% fipronil) 
(Agrovetmarket, Lima PERU) following the instructions on the label for control of ticks.  The 
product was dispensed along the dorsal midline from the neck to the base of the tail at a rate of 5 
ml per 50 kg body weight. One heifer received Labimectin® (1% ivermectin) (LabiPharma, 
Guatemala City, GUATEMALA) following the instruction on the label for control of intestinal 
roundworms.  The product was administered as an intramuscular injection at a dose of 1 ml per 
50 kg body weight. Two heifers remained untreated and served as control animals.  Because the 
fipronil was applied dermally, the three fipronil-treated heifers were separated from the other 
heifers for 48 hours after treatment to prevent the possibility of cross contamination due to 
normal huddling and herding activity of cattle.  Afterwards, the heifers were pastured together. 
Prior to treatment, a pre-treatment mosquito feeding was conducted on each heifer to 1) 
establish baseline information on mosquito feeding rates and post-feeding survival, and 2) 
optimize procedures for handling the cattle and conducting controlled mosquito feeds.  Two 
styles of polypropylene containers were tested for their suitability as feeding chambers; modified 
flat rectangular food storage containers and modified beverage cups.  Both had screened lids 
through which mosquitoes could feed and screened windows cut into the sides to reduce build-up 
of condensation while attached to the heifer.  Mosquito feeding rates and survival were better in 
the modified beverage cups; therefore, cups were used for the remainder of the study.  Feeding 
cups were re-used between trials.  However, to avoid potential residue contamination, filter paper 





each use.  In addition, cups were cleaned with isopropyl alcohol then exposed to sunlight for one 
or two days between use to promote photodegradation of any potential insecticidal residues.  
Experimental mosquito feedings were conducted at 2, 5, 7, and 14 days after cattle 
treatment.  The day before each feeding trial, mosquitoes were placed into feeding cups (15 to 40 
per cup).  Feeding cups were transported to the ranch by automobile (ca. 40 minutes) in an 
uncovered cooler to reduce humidity.  Feedings were conducted in the late afternoon (ca. 1530 to 
1730h, local time).  Cattle were herded into a corral that had at one side, an alley that led into a 
metal squeeze chute where cattle could be individually restrained during the mosquito feeding 
procedure.  Once a heifer was in the squeeze chute, two areas near the midline were shaved using 
a small battery-operated livestock clipper. Two cups, one on each side, were secured to the 
animal by encircling the animal’s midsection 2-4 times with plastic wrap. Mosquitoes were 
allowed to feed for 15 minutes, then the plastic was cut, and the cups were removed and 
transported back to the BVEC.  Unfed mosquitoes were removed with a glass aspirator, verified 
visually to be unfed, and then expelled into another, larger cage for dissection and parity 
determination the following morning (see above).  Experimental mosquito feedings were 
conducted at 2, 5, 7, and 14 days after treatment. 
Mosquito Mortality, Digestion and Ovarian Development.  Mosquito mortality was assessed 
by counting and removing dead mosquitoes from each feeding cup every day.  At the end of 4 
days, surviving mosquitoes were counted and dissected to assess blood meal digestion and 
ovarian development.  Blood meal digestion was scored as either negative (no traces of blood in 
the midgut) or positive (blood present in the midgut).  Ovarian development was scored as fully 
gravid (ovaries with fully developed ovarioles), half gravid (ovaries enlarged but ovarioles not 





Data Analyses.  Mosquito survivorship was analyzed with a Kaplan–Meier survival analysis and 
Logrank test (GraphPad Software, La Jolla, CA, USA).  Sub-lethal effects on ovarian 
development and blood meal digestion were analyzed using generalized linear mixed effects 
model (GLMM) in R (R package “lme4”) [5, 6]. The GLMM analysis was chosen because it 
provided greater flexibility when examining the categorical and continuous explanatory 
variables, fit well for binomial response variable, and accounted for random effects (i.e., heifer). 
After running full models, sub models were constructed to identify the best overall model that 
explained the data, based on AIC and null deviance.  Odds ratios with their respective confidence 
intervals were calculated in R, using the standard error of the models.  A 0.05 level of 
significance was used throughout. 
Results 
A total of 1783 wild-caught An. albimanus were exposed to cattle of which 1078 (60%) 
took a blood meal.  The ovaries of 373 unfed mosquitoes were successfully dissected and scored 
for parity. The overall parity rate was 62% (range 45% to 76%). The age structure of mosquitoes 
used during this study fluctuated over the 2-week course of the study. Mosquitoes used at day 7 
were physiologically younger (i.e., lower parity rate) than were mosquitoes used at days 2, 5, and 
14 after treatment (Figure 5.1).  A substantial proportion of An. albimanus (26% of 382 
examined) had an unknown species of larval ectoparasitic water mite attached to their thoraces 
and abdomen (Acari: Hydarchinida).  Infestations were generally light (geometric mean intensity 
= 1.7 mites per infested mosquito). Mosquitoes feeding on fipronil-treated cattle had no 
differences in feeding rate throughout the experiment (Table 5.1). However, mosquitoes feeding 





Throughout the duration of the trial, the median survival of mosquitoes feeding on 
fipronil-treated heifers was significantly less (p<0.05) than the median survival of mosquitoes 
fed on untreated heifers (Table 5.2; Figure 5.2).  Although overall mosquitocidal efficacy of 
fipronil treatments deteriorated by day 14 (Figure 5.2), the 4-day survival curve of mosquitoes 
fed on fipronil-treated heifers remained significantly different than the survival curve of 
mosquitoes fed on untreated heifers (Table 5.2).  At 2, 5, and 7 days after cattle treatment, the 
median survival of mosquitoes fed on the ivermectin-treated heifer was significantly less 
(p<0.05) than the median survival of mosquitoes fed on untreated heifers (Table 5.2; Figure 5.2).  
Efficacy of the ivermectin treatment dissipated during the second week and at day 14, the median 
survival of mosquitoes fed on the ivermectin-treated heifer did not differ significantly from the 
median survival of mosquitoes fed on untreated heifers (Table 5.2).  
Mosquito death after feeding on fipronil-treated heifers was rapid (Figure 5.2).  Many 
fipronil-treated mosquitoes became moribund within hours after feeding and most mosquito 
mortality occurred within 24 hours (median survival times = 1 day).  In contrast, mosquitoes fed 
on the ivermectin-treated heifer took several days to die (median survival times = 3 to 4 days) 
(Table 5.2).   
Overall, 85% of mosquitoes that fed on untreated heifers contained fully gravid ovaries at 
four days after blood feeding (n=228; range 78 to 91%) (Table 5.3).  Mosquitoes fed on fipronil-
treated heifers were significantly less likely to have fully developed ovaries compared to 
mosquitoes fed on untreated heifers (Table 5.4. p<0.0001, OR: 0.0314) and when averaged over 
the 14-day period, only 22 % (n=183; range 0 to 25%) of the mosquitoes fed on fipronil-treated 
heifers contained fully developed ovaries (Table 5.3). Likewise, mosquitoes fed on the 





mosquitoes fed on untreated heifers (Table 5.4. p=0.0001, OR: 0.169) and when averaged over 
the 14-day period, only 58% (n=89; range 50 to 60%) of the mosquitoes fed on the ivermectin-
treated heifer contained fully developed ovaries (Table 5.3). The influence of ‘day after 
treatment’ on mosquito gravidity was almost, but not quite significant (Table 5.4. p=0.07, OR: 
1.062). 
Most (95%) of the 228 mosquitoes that fed on untreated heifers digested their blood 
meals completely by four days and retained no trace of blood residue within the midgut (Table 
5.3).  Similarly, all of 183 mosquitoes fed on fipronil-treated heifers completely digested their 
blood meals and fipronil had no effect on blood meal digestion (Table 5.5. p=0.147, OR: 3.781).  
In contrast, ivermectin had a significant effect on blood meal digestion (Table 5.5. p=0.0019, 
OR: 0.201) and the proportion of fully digested blood meals in mosquitoes that fed on the 
ivermectin-treated heifer within the drug’s window of efficacy (i.e., days 2–7 after treatment) 
was 67% (n=12) which was significantly less than in mosquitoes fed on either the control 
(χ2=10.3, p=0.0013) or the fipronil-treated (χ2=36.2, p<0.0001) heifers (Table 5.3).  The 
influence of ‘day after treatment’ on mosquito digestion was significant (Table 5.5. p=0.0318, 
OR: 1.121), indicating that as time passed, more mosquitoes were able to fully digest their blood 
meals. 
Discussion 
In a pilot trial conducted in northern Belize, treatment of heifers with a single dose of two 
commercially-available livestock parasiticides – Ectonil® (1% fipronil pour-on formulation) and 
Labimectin® (1% ivermectin injectable formulation) – each yielded significantly higher post-
feeding mortality in field-collected A albimanus mosquitoes than did untreated control heifers.  





declining, mosquito mortality for up to 2 weeks after cattle treatment.  Efficacy of the 
Labimectin® treatment lasted 1 week.  In addition to lethal effects of the treatments, mosquitoes 
that survived feeding on treated heifers exhibited reduced ovarian development.  The sterilizing 
effect lasted for the duration of the two-week trial period but was much more pronounced in 
mosquitoes fed on fipronil-treated heifers.   
Physiologically, fipronil and ivermectin affected An. albimanus differently. Mosquito 
ingestion of fipronil produced rapid ‘knock-down’ and most of the mosquito mortality occurred 
within 24 hours.  Mortality in mosquitoes ingesting ivermectin was protracted and occurred over 
several days. Both compounds inhibited ovarian development but only ivermectin inhibited 
blood meal digestion. There was a substantial degree of concordance between blood feeding and 
ovarian development in mosquitoes fed on untreated heifers, with 95% of 241 engorged 
mosquitoes fully digesting their blood meals and 85% subsequently developing gravid ovaries.    
In contrast, ingestion of fipronil resulted in gonotrophic discordance, with 100% of 183 engorged 
mosquitoes fully digesting their blood meals but only 22% subsequently developing gravid 
ovaries. The effect that this ‘fipronil-mediated gonotrophic discordance’ has on the frequency of 
re-feeding by surviving An. albimanus was not examined. However, if fipronil-mediated 
gonotrophic discordance were to enhance re-feeding in the survivors, then the outcome could 
either be desirable (i.e., if re-feeding occurred on treated cattle) or undesirable (i.e., if re-feeding 
occurred on humans).  At this point, it is premature to speculate whether fipronil-mediated 
gonotrophic discordance would change the behavior of a normally zoophagic population to one 
of anthropophagy. 
Treatment of livestock with various formulations of fipronil and avermectin-based 





survival and fecundity of the zoophagic vectors, An. arabiensis in Africa [7, 9-11], and An. 
culicifacies and An. stephensi in Pakistan [8].  This study extends those findings and 
demonstrates that treatment of cattle with commercial livestock products may also be employed 
in the Americas to control zoophagic vectors.  The residual activities of the products used in this 
pilot trial were relatively short-lived (< 2 weeks).  Product formulation can influence the 
longevity of a compound’s residual effects.  For example, recent studies describe the 
development and field-testing of a slow-release silicone-based ivermectin implant for livestock 
that extended the mosquitocidal activity of ivermectin out to six months [7, 10].  Advances in 
product formulation (e.g, slow-release implants) to extend a compound’s residual activity, 
identification of multiple mosquitocidal compounds with different modes of action (e.g., 
avermectins versus fipronil), and strategic development of staggered treatment regimens can all 
contribute to optimizing the “mosquitocidal livestock” strategy against zoophagic malaria 
vectors. 
In conclusion, this pilot study provides proof of concept that treating cattle with 
commercially available livestock drugs such as fipronil and ivermectin can augment malaria 






Figure 5.1. Parity status of wild-caught Anopheles albimanus mosquitoes used in cattle feedings. 








































Figure 5.2. Residual mosquitocidal activity of cattle treated with fipronil (topical application) or 
ivermectin (intramuscular injection) via monitoring daily survival for 4 days post blood feeding. 
A. Survival of mosquitoes feeding 2 days post treatment. B. Survival of mosquitoes feeding 5 
days post treatment C. Survival of mosquitoes feeding 7 days post treatment D. Survival of 





Table 5.1. Proportion (+ standard deviation) of wild-caught Anopheles albimanus that ingested blood when exposed to treated and 
untreated heifers (Belize 2018) 
Treatment Number of heifers Pre-treatment 
Day after treatment 
Day 2 Day 5 Day 7 Day 14 
Control 2 43 + 9% 54 + 10% 62 + 9% 68 + 11% 79 + 6% 









Fipronil 3 51 + 8% 47 + 8% 65 + 7% 71 + 9% 74 + 5% 









Ivermectin 1 37% 24% 40% 51% 85% 































Table 5.2. Median survival in days of wild-caught Anopheles albimanus fed on treated and untreated heifers.  (Belize 2018.) 
 Pre-treat Day 2 Day 5 Day 7 Day 14 
Untreated heifers (n=2)      
   Mosquito survival (days) >4* (n=46) 4 (n=54) >4* (n=75) >4* (n=48) >4* (n=151) 
Fipronil-treated heifers (n=3)      
   Mosquito survival (days)  >4* (n=74) 1 (n=73) 1 (n=115) 1 (n=72) >4* (n=213) 
   Statistical significance** - χ2=96.8; p<0.0001 χ2=150.7; p<0.0001 χ2=23.7; p<0.0001 χ2=19.6; p<0.0001 
Ivermectin-treated heifer (n=1)      
   Mosquito survival (days)  4 (n=18) 3 (n=12) 4 (n=23) 2 (n=17) >4* (n=82) 
   Statistical significance** - χ2=4.2; p=0.04 χ2=27.1; p<0.0001 χ2=11.7; p=0.0006 χ2=0.08; p=0.78 
* Median mosquito survival exceeded the 4-day observation period; n=total number of engorged mosquitoes.   
** The χ2 and p-values compare survival curves of the treated groups with that of the corresponding untreated control group, as 





Table 5.3. Proportion of fully gravid mosquitoes and proportion of mosquitoes with full blood meal digestion (+ standard deviation) 
in Anopheles albimanus surviving four days after feeding on cattle.  
 Pre-treat Day 2 Day 5 Day 7 Day 14 
Untreated heifers (n=2)      
Fully gravid 78 + 14% 80 + 16% 91 + 7% 78 + 16% 86 + 8% 
Completed blood meal digestion 91 + 10% 100% 91 + 7% 93 + 10% 99 + 7% 
No. mosquitoes dissected N=32/n1=27, n2=5 N=25/n1=12, n2=13 N=64/n1=29, n2=35 N=27/n1=11, n2=16 N=80/n1=40, n2=40 
Fipronil-treated heifers (n=3)      
Fully gravid 83 + 15% 
a 
0% 0% 25 + 6% 
Completed blood meal digestion 96 + 8% 100% 100% 100% 









Ivermectin treated heifer (n=1)      
Fully gravid 50% 50% 50% 
a 
60% 
Completed blood meal digestion 75% 75% 63% 90% 
No. mosquitoes dissected N=4 N=4 N=8 N=2 N=77 
a Too few mosquitoes (<2) survived engorgement to make meaningful estimates. N total number of mosquitoes exposed to a treatment 





Table 5.4. Best-fit generalized linear mixed effects model (binomial) of variables and interactions that influenced ovary development 
in Anopheles albimanus feeding on treated cattle. 
Fixed effects Groups Estimate SE p-value Odds ratio (95% CI) 
Intercept  1.315 0.369 <0.0004 3.724 (3.000, 4.448) 
Treatment 
Control (n=196) - - - - 
Fipronil (n=185) -3.379 0.407 <0.0001 0.0314 (-0.764, 0.832) 
Ivermectin (n=91) -1.776 0.455 0.0001 0.169 (-0.722, 1.061) 
Day after treatment  0.060 0.033 0.07 1.062 (0.998, 1.126) 
Model: FullyGravid ~ Treatment + DayAfterTreat + (1|CowID), where the fixed effects were ‘Treatment’ (n = total number of 
mosquitoes dissected per treatment group) and ‘Day After Treatment’.  The random effect was ‘CowID’ (i.e., the six individual 





Table 5.5. Best-fit generalized mixed effects model (binomial) of variables that influenced blood digestion in Anopheles albimanus 
feeding on treated cattle. 
Fixed effects Groups Estimate SE p-value Odds ratio (95% CI) 
Intercept  2.181 0.486 <0.0001 8.852 (7.900, 9.804) 
Treatment 
Control (n=196) - - - - 
Fipronil (n=185) 1.595 1.100 0.147 3.781 (2.772, 7.085) 
Ivermectin (n=91) -1.661 0.534 0.0019 0.201 (-0.856, 1.236) 
Day post treatment  0.114 0.053 0.0318 1.121 (1.017, 1.225) 
Model: No blood meal ~ Treatment + Day post treatment + (1|CowID) where the fixed effects were ‘Treatment’ (n = total number of 
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IVERMECTIN FORMUATION AND BODY LOCATION AFFECT ANOPHELES 








The formulation of veterinary drugs and insecticides often plays a significant role in their 
effectiveness. Ivermectin is available in oral, intramuscular, subcutaneous, and topical 
formulations. Subcutaneous and oral formulations provide the greatest bioavailability ivermectin 
in the body, whereas topical formulations have the least bioavailability [1]. In the U.S. cattle 
industry, subcutaneous injection and topical applications are the most widely used ivermectin 
formulations. Although subcutaneous injection provides more available ivermectin in a cow’s 
circulation system, topical formulations (i.e., “pour-ons”) are more convenient because they do 
not require syringes and are generally less stressful on animals and handlers when treating large 
herds. Because ivermectin is highly lipophilic, dispersion from the application site (typically 
along the back of the animal) may proceed more slowly when applied as a pour-on rather than an 
injection, because with a pour-on, the drug is absorbed into and becomes trapped within the 
layers of the skin [2].  
 The dispersion of injected versus topically applied ivermectin when given to a large 
mammal such as a cow has never been examined in relation to its efficacy to kill Anopheles 
mosquitoes that feed on treated animals. This is important information because it is known that 
mosquitoes not only have preferred hosts, feeding times, and resting behaviors, but also vary in 
the anatomical site on a host in which they prefer to feed [3, 4]. Some mosquitoes, like Culex 
quinquefasciatus feed indiscriminately on the body [3]. Others like the African vectors, 
Anopheles gambiae, An. arabiensis and An. funestus habitually bite around the feet and ankles, 
while Aedes aegypti, An. atroparvus, and An. albimanus often feed around the head, neck, and 
shoulders [3-5]. These predilections may change depending on the region and whether the area is 





it is not unreasonable to speculate that similar preferences also exist with zoophagic mosquitoes 
feeding on livestock.   
The purpose of this study was to evaluate survival of colony-reared Anopheles stephensi, 
a dominant South Asian vector, fed on different body parts of cattle treated either subcutaneously 
or topically applied ivermectin. The colony strain of mosquitoes, Anopheles stephensi (STE-2) is 
susceptible to ivermectin at low concentrations, making it an ideal species to use in this 
experiment (Chapter 2). The goals of this study were to determine if ivermectin formulation 
affects feeding rate, how long residual insecticidal effects lasted, if the body location the 
mosquitoes fed on influenced survival and did formulation or body location affect blood meal 
digestion of surviving mosquitoes.  
Materials and Methods 
Mosquitoes.  Laboratory colonies of Anopheles stephensi strain were obtained as eggs through 
BEI Resources (Manassas, VA USA). Mosquitoes were reared in the University of North Dakota 
insectary at a photoperiod of 12-h light:12-h dark and a temperature of 26 °C. Eggs were hatched 
in trays of dechlorinated water. Larvae were fed fish food (Tetra ®) ground to a fine powder in 
an electric coffee grinder. Pupae were placed into ca. 28 l wire mesh holding cages to emerge. 
Adults were given access to water and a sugar source. One to two hours before feedings, female 
mosquitoes, at least 3 days old, were aspirated from holding cages into the feeding containers 
(20-70 per container). Feeding containers were transported to the NDSU Dairy Barn by 
automobile (~1-hour travel time) in plastic or Styrofoam storage containers. 
Cattle treatment and mosquito feeds.  Experiment was conducted at the North Dakota State 
University Dairy Barn, located in Fargo, North Dakota. Twelve 6-week-old Holstein heifer 





randomly sorted into three groups, two treatment and one control group. Treatment group one 
received a subcutaneous injection of 1% ivermectin (Durvet®, 1 mL per 50 kg body weight). 
Treatment group two received ivermectin pour-on, applied along the dorsal midline from neck to 
the base of the tail (Durvet®, 1 mL per 10 kg body weight). The last group was left untreated as 
a control. Calves were tied inside a large indoor pen using a halter rope for treatment and 
mosquito feedings and between mosquito exposures housed individually in calf hutches 
(PolyDome ®) to prevent the calves from rubbing against or licking one another and causing 
cross-contamination between treatments.  
 Prior to treatment, a pre-treatment mosquito feed was conducted on each heifer to 
establish baseline information on mosquito feeding rates and post-feeding survival, and to 
optimize the procedure for calf handling and subsequent mosquito feeds. Groups of mosquitoes 
were fed simultaneously on the back, belly, and above the hock. Feeding chambers for the back 
and belly feeds were constructed out of flat, rectangular, food storage containers which had 
screened lids to allow mosquitoes to feed through, screened windows cut in the sides to reduce 
condensation buildup within the containers and filter paper placed into the container bottom to 
keep the containers clean and provide a place for mosquitoes to rest. Feeding chambers for the 
leg feeds were constructed out of 4-inch lengths of cardboard mailing tubes with a large 
rectangular screened hole for the mosquitoes to feed through and a screened cap for ventilation. 
Containers were reused for each mosquito feed; They were wiped out using a damp paper towel, 
allowed to dry, and the filter paper in the plastic containers was replaced after each feed.  
 Controlled mosquito feedings were conducted 2, 5, 9, 14, and 23 days after the initial 
cattle treatment. Feedings were conducted in the mornings (900 to 1100 h, local time). On day 9 





leg cages were filled. Once calves were secured using a halter rope, an area near the dorsal 
midline, one on the belly, and one just dorsal to the hock (tibial joint) was shaved using a small 
rechargeable livestock clipper. One container was secured to the back, one to the belly, and one 
to the leg using plastic wrap encircling the area 2-4 times. Mosquitoes were allowed to feed for 
15-20 minutes, after which the plastic was cut, and the containers removed. Mosquitoes were 
transported back to the University of North Dakota insectary. Unfed and partially fed mosquitoes 
were removed using a mouth aspirator and discarded. Fully engorged mosquitoes were removed 
from the feeding containers and aspirated into pint cardboard recovery cages. These mosquitoes 
were maintained in the insectary with a photoperiod of 12-h light:12-h dark, at a temperature of 
26 °C, and had access to cotton soaked in a 10% sucrose solution.  
Mosquito mortality, digestion, and ovarian development.  Mosquito mortality was assessed 
every 24 hours by counting and removing the dead mosquitoes from each recovery cage. At the 
end of 7 days, surviving mosquitoes were counted and dissected to evaluate blood meal digestion 
and ovarian development. Blood meal digestion was scored either positive (blood present in 
midgut) or negative (no blood present in midgut).  
Data analysis.  Feeding rate, blood meal digestion, and ovarian development differences 
between the treatments and body positions were analyzed using a chi-square analysis test 
(GraphPad Software, La Jolla, CA, USA). The belly was used as the control while analyzing the 
feeding rate at different body locations, as this allowed use the day 9 treatment data in the 
analysis. A Kaplan-Meier survival analysis and Logrank test (GraphPad Software, La Jolla, CA, 
USA) was used to analyze differences in mosquito survivorship between the different treatments 






 The twelve calves were exposed to a total of A total of 9359 Anopheles stephensi 
mosquitoes: 1407 mosquitoes during the initial pre-treatment (an average of 117 mosquitoes per 
calf per exposure) and 7972 during the 23-day post-treatment (an average of 142 mosquitoes per 
calf per exposure). Separate cohorts of mosquitoes were used at each exposure interval. The 
overall feeding rate during the post-treatment period was 70.6% and the overall survival during 
handling and transport between the NDSU Dairy Facility and UND insectary was 97.2%. The 
pre-treatment showed differences in feeding rate in the mosquitoes feeding on the 12 different 
calves (p<0.01). However, this resolved on day 23 post treatment (p=0.32).  
Mosquitoes were significantly less likely to feed upon calves treated with topically 
treated ivermectin than mosquitoes fed on control cattle (χ2=137.7, p<0.0001). There was no 
significant difference in the feeding rate of An. stephensi fed on calves treated with injectable 
ivermectin compared to mosquitoes fed on control calves (χ2=3.004, p=0.0831). As the 
experiment progressed, mosquitoes feeding on topically treated calves had an increased feeding 
rate, though their feeding rate was always significantly less than those feeding on the control 
calves (Table 6.1). Mosquitoes feeding on calves treated with injectable ivermectin showed no 
significant difference in feeding rate than mosquitoes feeding on control calves on most days 
sampled post treatment. However, on day 14 post treatment, mosquitoes feeding on the injected 
calves had a significantly worse feeding rate than their control counterparts (Table 6.1). The 
feeding rate returned to normal by day 23 post treatment (Table 6.1) 
Overall, mosquitoes significantly fed less on the leg (χ2=236.6, p<0.0001) and on the 
back (χ2=103.9, p<0.0001) compared to mosquitoes fed on the calf bellies. There was one 





significantly less than those on the belly (Table 6.2) On day 23, the mosquitoes fed on the backs 
of calves again fed significantly less than those feeding on the bellies (Table 6.2). Mosquitoes 
feeding on the legs of calves always fed significantly less than those feeding on the bellies, no 
matter what day post treatment (Table 6.2) 
Both ivermectin formulations resulted in significant decreases in mosquito survival 
compared to mosquito survival in the control starting on day 2 post treatment and continuing 
until day 14 post treatment (Figures 6.1-6.5). On days 2-9 post treatment, mosquito survival was 
reduced no matter where the mosquito fed (Figures 6.1-6.3). There was a loss of efficacy in the 
injectable formulation starting on day 14 post treatment, and mosquitoes feeding on the legs of 
calves treated with injectable ivermectin showed no significant difference survival compared to 
mosquitoes feeding on control (Figure 6.4c). Topically applied ivermectin was still effective no 
matter where the mosquitoes fed on day 14 post treatment (Figure 6.4). On day 23 post 
treatment, only mosquitoes that fed on the back of calves treated with topically applied 
ivermectin had decreased survival compared to those feeding on calves treated with injected 
ivermectin or those feeding on other parts of the calves’ body (Figure 6.5). The median survival 
of the treated groups was significantly lower than the control groups from day 2 post treatment 
until day 9 post treatment (Table 6.3). While there were significant differences between the 
treatment effectiveness on the back and belly, there were no consistent patterns of speed of kill 
or lethality until day 14 and 23, where topical ivermectin was more lethal and worked more 
effectively than injectable ivermectin (Table 6.3; Figures 6.4, 6.5).  
 Only blood meal digestion and ovarian development data from 9-, 14-, and 23-days post 
treatment was used for analysis, as there were not enough surviving mosquitoes from days 2 and 





to examine if they fully digested their blood meals and had fully developed ovaries. Mosquitoes 
feeding on topically applied (χ2=233.9, p<0.0001) and injected (χ2=166.0, p<0.0001) ivermectin 
were less likely to digest their blood meals seven days post feed than mosquitoes feeding on the 
control calves. There were no significant differences between mosquitoes feeding on the back, 
belly, or leg of the control calves (χ2=3.06, p=0.217). Mosquitoes feeding on either injected or 
topical-treated calves nine days post treatment were significantly less likely to fully digest their 
blood meals than control mosquitoes (Table 6.4). When fed on calves 14 days post treatment, 
mosquitoes were significantly less likely to fully digest their blood meals, but the drug effects 
were beginning to wane (Table 6.4) By day 23 post treatment, mosquitoes fed on injected 
ivermectin calves no longer had a significant difference in blood meal digestion compared to the 
controls (Table 6.4). Mosquitoes that fed on the topically treated ivermectin calves 23 days post 
treatment were still slightly less likely to fully digest their blood meal (Table 6.4).  
 Overall, mosquitoes feeding on calves treated with topically applied ivermectin (χ2=64.5, 
p<0.0001) and those feeding on calves treated with injected ivermectin (χ2=44.4, p<0.0001) did 
not have fully developed ovaries 7 days after feeding compared to those feeding on control 
calves. Mosquitoes feeding on calves treated with either topical or injected ivermectin were 
significantly less likely to have fully developed ovaries at days 9 and 14 post treatment than 
mosquitoes feeding on the controls (Table 6.5). On day 23 post treatment, there was no 
significant difference in ovarian development between mosquitoes feeding on control calves 
versus those feeding on calves treated with injectable ivermectin (Table 6.5). Mosquitoes feeding 
on calves treated with topical ivermectin were still less likely to have fully developed ovaries 






 Mosquitoes exposed to calves topically treated with ivermectin were less likely to feed 
compared to the mosquitoes exposed to calves treated with injectable ivermectin or untreated 
calves. There have been no studies examining a potential repellant effect of topically applied 
ivermectin against mosquitoes. Topical ivermectin repellency was not observed for host-seeking 
Culicoides midges when sticky traps were mounted onto the backs of topical ivermectin treated 
versus untreated cattle [6]. Other experiments using ivermectin in cattle have not reported 
repellency from any ivermectin formulations. However, many dung-colonizing insects are 
repelled by ivermectin in dung pats, so it is not inconceivable that ivermectin could have a 
repellency [7]. The injectable ivermectin formulation exhibited no repellent effect on An. 
stephensi except on day 14 post treatment. This discrepancy can be explained by problems in 
securing the leg cages on day 14, leading to lower feed rates in the leg cages. This resolved by 
day 23 post treatment. In our previous work in Belize, there was no repellant effect in 
mosquitoes feeding on the heifer treated with injectable ivermectin, supporting our observations 
here (Chapter 5). Topical ivermectin was extremely effective by reducing An. stephensi survival 
and fecundity and it was long-lasting. The repellency we observed with topically applied 
ivermectin may be an issue. However, even though there was repellency, the proportion of fed 
mosquitoes was still between 60-70% and the proportion increased as the experiment went on. 
Coupled with the easy application for farmers and ranchers and the long-lasting effects on 
survival and fecundity, topical ivermectin is the best candidate for veterinary systemic 
parasiticide vector control.  
 Ivermectin reduced mosquito survival no matter the formulation. This is consistent with 





throughout the body, even when topically applied. Ivermectin is highly lipophilic and will persist 
in the plasma of treated animals for several days or weeks, depending on the formulation [1, 2, 
14-16]. Most research on the pharmacodynamics of ivermectin focus on subcutaneous or 
intramuscular injection and the concentration of drug present in the plasma. Two studies using 
topical formulations in cattle, one using ivermectin and one using moxidectin reveal differences 
in how the compounds are sequestered and released. Topical ivermectin has low bioavailability 
compared to other routes of administration (such as subcutaneous injection or oral 
administration) but persists for a long period of time [1]. It is hypothesized that as topical 
ivermectin (or moxidectin in the case of Sallovits et al. [17]) is absorbed, it becomes trapped 
within the layers of the skin and is slowly released over time [1, 2, 17]. This explains the 
persistence of lethality seen in the topical ivermectin group, when injectable ivermectin was no 
longer effective. Interestingly, on day 23 post treatment, topical ivermectin was only effective on 
mosquitoes that fed on the backs of treated animals, near the site of the drug application. 
Sallovitz et al. [17] demonstrated how moxidectin sequesters in high concentrations in the 
epidermis and dermis near the application site and in areas of high fat concentration (such as the 
thighs) and releases over time, leading to high availability in other body locations after several 
weeks. Ivermectin may work similarly and if this is the case, ingestion may not be the only route 
of administration. Instead, mosquitoes probing for a blood meal may be contacting sequestered 
ivermectin in the skin and absorbing the drug through the cuticle. Blood samples were taken 
from the treated animals and will be analyzed to determine the concentration of ivermectin in the 
treated animals, which may confirm this hypothesis.  
Determining where mosquitoes preferentially bite cattle will be important in treating 





ivermectin and if mosquitoes preferentially feed on the back of treated cattle, this will make it 
much easier to implement widespread treatment for vector control purposes. If mosquitoes 
preferentially feed elsewhere on the cattle, other methods of application, such as spraying cattle 
further down on the body or using foot baths/drenches would be necessary to effectively target 
the mosquito.  
 Mosquitoes that fed day 9 and 14 post treatment on calves treated with either injectable 
or topically applied ivermectin were less likely to fully digest their blood meals or become fully 
gravid. Injectable ivermectin no longer affected mosquito blood meal digestion or ovarian 
development at day 23 post treatment. Topical ivermectin was still effective at reducing ovarian 
development, and to a lesser degree slowed blood meal digestion. We used the same 
methodology in Belize to examine fecundity in treated mosquitoes and found similar results; 
when mosquitoes feed on the cow treated with an ivermectin intramuscular injection had slowed 
blood meal digestion and ovarian development (Chapter 5). Interestingly, during the Belize 
study, we found blood meal digestion was inhibited only until day 7 post treatment but had 
returned to normal by day 14 post treatment (Chapter 5). In this study, a subcutaneous injection 
of ivermectin reduced blood meal digestion for up to 14 days but had returned to normal by day 
23 post treatment. The increased bioavailability of subcutaneously injected ivermectin could 
explain why ivermectin reduced blood meal digestion for a longer period.  
Other studies using ivermectin treated cattle have also demonstrated the inhibition of 
blood meal digestion. Lyimo et al. [8] examined blood meal digestion of An. arabiensis fed on 
cattle subcutaneously injected with ivermectin, by quantifying the amount of blood protein 
(haematin) defecated after 4 days, with lower amounts of haematin defecated indicating reduced 





for up to 9 days post treatment, returning to normal after day 12 post treatment [8]. Similarity 
both Lyimo et al [8] and Fritz et al. [11] demonstrated a reduction in egg production in An. 
arabiensis and An. gambiae s.l. fed on cattle treated with subcutaneously injected ivermectin, 
corresponding to the results in this study, though we only examined ovarian development and not 
oviposition/egg production. While the lethal effects of ivermectin are important in stamping out 
residual malaria, reducing reproductive ability in the population will also assist to ensure residual 
malaria will not be able to persist in the mosquito population. 
In conclusion, both topically applied and subcutaneously injected ivermectin were 
effective at both killing mosquitoes and reducing their fecundity. However, despite a repellent 
effect, the long-lasting residual effects of topically applied ivermectin and ease of application 
and would be the best option for livestock-mediated vector control. By using this information 
and studying where mosquitoes preferentially bite on cattle, we can customize systemic 





Table 6.1. Effect of ivermectin formulation on An. stephensi feeding rate. Treatments compared to the control group using chi-square 





Average feeding rate 
(95% CI) Chi-square p-value 
Odds ratio  
(95% CI) 
0 
Control 437 0.43 (0.20, 0.67) - - - 
Topical 445 0.60 (0.46, 0.76) 47.2 <0.0001 2.87 (2.10, 3.89) 
Injection 527 0.17 (0.05, 0.28) 71.1 <0.0001 0.311 (0.237, 0.408) 
2 
Control 669 0.71 (0.51, 0.90) - - - 
Topical 636 0.45 (0.26, 0.64) 80.5 <0.0001 2.80 (2.23, 3.51) 
Injection 621 0.69 (0.49, 0.88) 1.60 0.205 0.855 (0.672, 1.09) 
5 
Control 532 0.81 (0.66, 0.95) - - - 
Topical 538 0.63 (0.44, 0.82) 45.2 <0.0001 2.51 (1.91, 3.29) 
Injection 558 0.85 (0.73, 0.97) 1.33 0.249 0.838 (0.624, 1.14) 
9 
Control 337 0.89 (0.77, 1.0) - - - 
Topical 247 0.73 (0.55, 0.91) 12.3 0.0004 2.13 (1.40, 3.22) 
Injection 244 0.84 (0.65, 1.0) 1.66 0.198 1.35 (0.860, 2.15) 
14 
Control 769 0.72 (0.51, 0.94) - - - 
Topical 732 0.67 (0.53, 0.82) 16.2 <0.0001 1.59 (1.27, 1.99) 
Injection 645 0.64 (0.45, 0.83) 44.6 <0.0001 2.16 (1.72, 2.70) 
23 
Control 456 0.78 (0.65, 0.90) - - - 
Topical 455 0.69 (0.53, 0.86) 11.7 0.0006 1.67 (1.25, 2.24) 





Table 6.2. Effect of body location on An. stephensi feeding rate. Treatments compared to the belly group using a chi-square analysis. 
Odds ratio indicates likelihood of mosquitoes not being engorged compared to those feeding on the belly mosquitoes (>1=more 





Average feeding rate 
(95% CI) Chi-square p-value 
Odds ratio  
(95% CI) 
0 
Belly 422 0.57 (0.41, 0.73) - - - 
Back 455 0.43 (0.20, 0.67) 17.3 <0.0001 1.76 (1.35, 2.30) 
Leg 527 0.19 (0.05, 0.32) 143.9 <0.0001 5.48 (4.12, 7.35) 
2 
Belly 817 0.75 (0.56, 0.95) - - - 
Back 790 0.57 (0.34, 0.80) 52.8 <0.0001 2.17 (1.76, 2.68) 
Leg 319 0.52 (0.36, 0.68) 58.8 <0.0001 2.82 (2.14, 3.68) 
5 
Belly 472 0.88 (0.80, 0.95) - - - 
Back 528 0.73 (0.58, 0.88) 35.6 <0.0001 2.65 (1.92, 3.65) 
Leg 673 0.68 (0.47, 0.90) 52.1 <0.0001 3.06 (2.24, 4.18) 
9 
Belly 453 0.87 (0.77, 0.96) - - - 
Leg 375 0.77 (0.62, 0.93) 6.48 0.012 1.59 (1.10, 2.26) 
14 
Belly 681 0.76 (0.60, 0.91) - - - 
Back 627 0.76 (0.59, 0.94) 1.45 0.228 0.854 (0.657, 1.10) 
Leg 838 0.52 (0.34, 0.70) 79.7 <0.0001 2.70 (2.17, 3.36) 
23 
Belly 489 0.79 (0.70, 0.92) - - - 
Back 510 0.72 (0.54, 0.89) 7.26 0.007 1.49 (1.11, 1.99) 
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Figure 6.1. Survival of An. stephensi feeding from different body locations on calves 2 days post 
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Figure 6.2. Survival of An. stephensi feeding from different body locations on calves 5 days post 
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Figure 6.3. Survival of An. stephensi feeding from different body locations on calves 9 days post 
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Figure 6.4. Survival of An. stephensi feeding from different body locations on calves 14 days 
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Figure 6.5. Survival of An. stephensi feeding from different body locations on calves 23 days 





Table 6.3. Median survival times (days) for An. stephensi feeding on calves treated with 
injectable or topical ivermectin and feeding on different body locations (continued on page 104)  
Day post 





Back 158 5 
Belly 230 5 
Leg 76 5 
Injection 
Back 173 2 
Belly 225 2 
Leg 36 2 
Topical 
Back 50 2 
Belly 171 2 
Leg 44 2 
5 
Control 
Back 115 >7* 
Belly 121 >7* 
Leg 176 >7* 
Injection 
Back 155 2 
Belly 157 2 
Leg 193 3 
Topical 
Back 98 1.5 
Belly 132 2 
Leg 82 3 
9 
Control 
Belly 147 >7* 
Leg 146 >7* 
Injection 
Belly 125 3 
Leg 74 4 
Topical 
Belly 110 4 
Leg 78 4 






Table 6.3 continued. Median survival times (days) for An. stephensi feeding on calves treated 
with injectable or topical ivermectin and feeding on different body locations. 
Day post 





Back 181 >7* 
Belly 182 >7* 
Leg 209 >7* 
Injection 
Back 129 >7* 
Belly 197 >7* 
Leg 76 >7* 
Topical 
Back 159 >7* 
Belly 161 >7* 
Leg 154 >7* 
23 
Control 
Back 121 >7* 
Belly 116 >7* 
Leg 123 >7* 
Injection 
Back 146 >7* 
Belly 167 >7* 
Leg 58 >7* 
Topical 
Back 98 >7* 
Belly 107 >7* 
Leg 99 >7* 






Table 6.4. Proportion of mosquitoes fully digesting their blood meal after feeding on treated calves several days after treatment. Odds 
ratio indicates likelihood of mosquitoes feeding on treated animals retaining their blood meal compared to mosquitoes feeding on 











digesting a blood meal 
(95% CI) 
Chi-square p-value Odds ratio  (95% CI) 
9 
Control 284 0.99 (0.98, 1.00) - - - 
Topical 31 0.64 (0.38, 0.91) 106.5 <0.0001 0.013 (0.004, 0.047) 
Injection 36 0.30 (0.07, 0.52) 151.1 <0.0001 0.008 (0.002, 0.029) 
14 
Control 566 1.00 (0.99, 1.00) - - - 
Topical 338 0.66 (0.51, 0.82) 210.2 <0.0001 0.004 (0.0004, 0.020) 
Injection 348 0.75 (0.63, 0.87) 176.8 <0.0001 0.005 (0.0004, 0.026) 
23 
Control 344 0.97 (0.93, 1.00) - - - 
Topical 264 0.95 (0.91, 1.00) 3.23 0.073 0.408 (0.153, 1.11) 





Table 6.5. Proportion of mosquitoes with fully developed ovaries after feeding on treated calves several days after treatment. Odds 
ratio indicates likelihood of mosquitoes feeding on treated animals not having fully developed ovaries compared to those feeding on 









Proportion of fully 
gravid mosquitoes 
(95% CI) 
Chi-square p-value Odds ratio  (95% CI) 
9 
Control 284 0.90 (0.83, 0.97) - - - 
Topical 31 0.36 (0.04, 0.69) 87.6 <0.0001 27.4 (10.8, 64.6) 
Injection 36 0.26 (0, 0.53) 71.7 <0.0001 16.8 (7.80, 37.1) 
14 
Control 566 0.93 (0.90, 0.96) - - - 
Topical 338 0.79 (0.71, 0.88) 25.1 <0.0001 2.77 (1.84, 4.18) 
Injection 348 0.75 (0.62, 0.89) 38.7 <0.0001 3.37 (1.13, 4.98) 
23 
Control 344 0.62 (0.56, 0.69) - - - 
Topical 264 0.54 (0.40, 0.67) 5.17 0.023 1.46 (1.05, 2.01) 
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POTENTIAL MECHANISMS OF IVERMECTIN TOLERANCE IN THE ‘STECLA’ 






 In Chapter 2 I reported the most used laboratory strain of Anopheles albimanus, the Santa 
Tecla, or ‘STECLA’ strain was highly resistant to orally ingested ivermectin (LC50=1468 ng/ml) 
whereas a wild population of An. albimanus collected in northern Belize was susceptible to 
orally ingested ivermectin (LC50=26 ng/ml). The wild population’s susceptibility to ivermectin 
is consistent with other species tested to date (Table 2.1). The STECLA strain was originally 
isolated in Santa Tecla, El Salvador and has been in continuous colony at the CDC since the mid-
1970s [23]. This long period of inbreeding and its remarkable tolerance of ivermectin suggested 
that the genetic makeup of the STECLA strain may not be representative of the entire An. 
albimanus species. This poses a problem, as STECLA is the only readily available An. 
albimanus strain readily available to researchers through BEI Resources, a federally supported 
resource center for infectious disease reagents, and is the strain on which genome sequencing 
efforts for the species have been based. In addition, the report of ivermectin tolerance in the 
STECLA strain [8] has been a source of concern for other researchers involved in promoting 
ivermectin for a global anti-malarial tool [67].  
While ivermectin tolerance has not been observed in any wild anopheline populations to date, 
the high degree of ivermectin tolerance exhibited by An. albimanus STECLA indicates that some 
unidentified mechanism(s) may exist within wild anophelines that allows for the development of 
ivermectin resistance. Thus, the mechanisms involved in the observed ivermectin tolerance of the 
STECLA strain was investigated to better understand the phenomenon and to better mitigate the 
potential development of ivermectin resistance in field populations. demonstrates the potential of 
mosquitoes to develop ivermectin resistance.  





1. Behavioral Resistance: Individuals within an insect population may exhibit atypical 
behaviors that result in the overall reduction in the population’s exposure to insecticides. 
For example, insecticide-treated bed nets target mosquitoes that display an innate 
behavior to enter houses at night and feed on sleeping humans. The odd individuals that 
tend to feed earlier in the evening or outdoors and will through their ‘aberrant’ behavior, 
avoid lethal contact with insecticide-treated bed nets and are more likely to survive and 
pass on their genes (including their behavioral traits) to their offspring. This has been the 
case in parts of Africa. In Benin, after three years of increased bed net coverage, the local 
vectors shifted their biting patterns to biting during the early morning and outdoors, 
which diminished the effectiveness of insecticide-treated bed nets [1] 
2. Physiological Resistance: Insecticide toxicity may be reduced through various 
alterations in insect physiology. Physiological resistance may involve structural 
biochemistry or “target site resistance” (i.e., resistant phenotypes may display decreased 
binding of insecticides to neuronal or synaptic targets), fat body metabolism or 
‘metabolic resistance” (i.e., resistant phenotypes more efficiently sequester, metabolize, 
or excrete an insecticide), or absorptive properties (i.e., resistant phenotypes display 
reduced absorption of an insecticide through the cuticle and/or midgut tissue) [2]. 
Here, I looked at three potential mechanisms that might account for An. albimanus STECLA 
ivermectin tolerance. 
1. Absorption hypothesis. An. albimanus STECLA has a midgut barrier, that inhibits 
ivermectin from reaching its target, the glutamate-gated chloride channels (GluCls) 
imbedded in the synaptic membranes of the central nervous system and at the 





2. Metabolism hypothesis. An. albimanus STECLA maintains elevated levels and/or a 
more efficient cytochrome P450 system than other anopheline species. Cytochrome 
P450 is a large superfamily of enzymes responsible for the breakdown of many toxic 
compounds.  
3. Target site alteration hypothesis: The primary target of ivermectin is the 
glutamate-gated chloride channel (GluCl). I hypothesize An. albimanus STECLA 
has changes in the structure of their GluCls that sufficiently inhibit ivermectin 
binding.  
Absorption hypothesis.  A mosquito’s digestive system consists of the foregut, midgut, and 
hindgut. The midgut itself is separated into an anterior and posterior section. The midgut is 
lined with a single layer of epithelium with cuboidal digestive cells [3, 4]. Absorption of 
nutrients and other molecules, including ivermectin only occurs in the midgut, with the 
anterior midgut primarily responsible in sugar absorption and the posterior midgut 
responsible for blood meal digestion. An extracellular layer membrane that encloses the food 
bolus, the peritrophic matrix, is also formed in the midgut. The peritrophic matrix is essential 
in insect immune defense [4–6].  The peritrophic matrix is predominantly composed of chitin 
and glycoproteins, slows down digestion and mediates the flow of molecules in and out of 
the midgut lumen [4]. Once free of the matrix, the molecule can escape the midgut through 
the epithelial cells and into the hemocoel [3, 7].  
 While the midgut and peritrophic matrix slow blood meal digestion, they play a key role 
in filtering bacteria, viruses, and parasites. Viruses must escape the midgut before the 





for some time and may sequester themselves within the peritrophic matrix to grow and avoid 
digestive enzymes [3, 7].  
 Ivermectin is a large molecule and takes longer to kill mosquitoes compared to small 
molecules like fipronil [8]. Therefore, it is possible that either a peritrophic matrix or another 
midgut barrier may be working to keep ivermectin from reaching the hemocoel and away 
from its target, the GluCls. To test this hypothesis, I performed intrathoracic injections in 
Anopheles stephensi and Anopheles albimanus STECLA. I calculated LC50 data from the 
injections to compare to the ingested LC50 values in Chapter two [8] 
Metabolism hypothesis. while there are several enzymes involved in insecticide 
metabolism, the cytochrome P450s are the primary enzymes responsible for the breakdown 
of insecticides and other toxic compounds [10, 12, 14]. The cytochrome P450 enzyme 
superfamily members, are found in all kingdoms of life and are incredibly diverse.  Several 
genes and allelic variants have been identified, some of which are responsible for pyrethroid 
resistance in insects. Overexpression of specific P450 alleles increase insecticidal 
degradation, either slowing the speed or even fully degrading insecticides to the point they 
cannot reach target receptor [14, 15]. Pyrethroid and DDT resistance due to P450s has been 
identified in several species of mosquitoes including An. gambiae s.s., An. funestus, An. 
albimanus, and Culex quinquefasciatus [15–19].  
 Cytochrome P450 enzymes are also responsible for the metabolism of ivermectin. In 
insects, the detoxification of ivermectin via P450 enzymes is poorly understood. However, 
when treating Aedes aegypti with ivermectin, Deus et al. [20] demonstrated permethrin 
resistant strains of Ae. aegypti displayed cross resistance to ivermectin. Inhibition of the 





demonstrated by Nicolas et al. [80] and Chaccour et al. [21]. Since permethrin and 
ivermectin are detoxified using the same enzymes and display cross resistance, we can use 
permethrin to test whether ivermectin tolerance in STECLA is due to metabolic resistance.  
I tested Anopheles albimanus STECLA were tested using the CDC bottle test for 
permethrin resistance. In parallel, I also tested the laboratory strains An. stephensi, Aedes 
aegypti F39, and Culex pipiens CPCO were also tested for comparison and to identify any 
other species/strains displaying permethrin resistance.  All strains tested have been in colony 
for several years and are considered “wild-type”, with no prior resistances to insecticides.  
Target site hypothesis.  Structural, three-dimensional changes in receptors may also be 
responsible for resistance. Several species of Anopheles, including wild Anopheles albimanus, 
are sensitive to ivermectin [Chapter 2, 24–36], while An. albimanus STECLA and other 
mosquito species like Aedes aegypti are not susceptible to ivermectin [8, 20].  
Ivermectin sensitivity or resistance has been observed in other invertebrates, directly 
linked to mutations within the GluCls. For example, ivermectin sterilizes Brugia malayi, the 
nematode responsible for lymphatic filariasis. Brugia malayi displays high expression of GluCls 
in their reproductive tissues, which may explain why ivermectin has this effect on the nematodes 
[38]. Other studies have examined how point mutations and structural differences within the 
receptor are responsible for ivermectin resistance in nematodes and arthropods [39, 40]. To 
examine potential structural changes in the GluCls, I analyzed the GluCl sequences of two Aedes 
species and several Anopheles species (including the An. albimanus STECLA) using modelling 





Materials and Methods 
Mosquitoes.  Laboratory colonies of Anopheles. albimanus STECLA strain, An. stephensi STE2 
strain, and Aedes aegypti F39 strain were obtained as eggs through BEI Resources (Manassas, 
VA USA). Anopheles stephensi STE2, originally from BEI Resources, has been in continuous 
colony at the University of North Dakota Biology Department since 2001.Culex pipiens CPCO 
eggs were obtained in 2015 from a colony established at the Colorado State University, 
Arthropod-borne and Infectious Diseases Laboratory (Fort Collins, CO USA). Mosquitoes were 
reared in the UND Biology Department insectary at a photoperiod of 12-h light:12-h dark and a 
temperature of 26 °C. Eggs were hatched in trays of dechlorinated water. Larvae were fed fish 
food (Tetra Pond Sticks, Tetra, Blacksburg, VA USA) ground to a fine powder in an electric 
coffee grinder. Pupae were placed into ca. 28 l wire mesh cages to emerge. Adults were given 
access to water and a sugar source. 
Intrathoracic injection. Female mosquitoes 3–7 days old for use in intrathoracic injection 
toxicity studies were aspirated from rearing cages into smaller (ca. 0.5 l), cylindrical cardboard 
containers with mesh tops at a density of 15–40 mosquitoes per cage. Only An. albimanus 
STECLA and An. stephensi were used for the injection experiments. Mosquitoes were 
immobilized by chilling (@ -20 C for ca. 20 seconds), then quickly transferred to filter paper 
onto a chill table (BioQuip, Rancho Dominguez, CA, USA). To perform injections, a semi-
automated micro-injector (TriTech Research, Los Angeles CA, USA) was fitted with fine-tipped 
glass needles made with a micropipette puller (World Precision, Sarasota FL, USA). Ivermectin 
dilutions were prepared in the same manner as the blood-fed ivermectin solutions but were 
diluted into an insect salt solution instead of blood [41]. Mosquitoes were injected with 0.4 µl of 





appropriately labeled recovery cages. Injected mosquitoes were provided 10% sucrose solution 
and checked daily for three days.  Dead mosquitoes were counted and removed.  After three 
days, the surviving mosquitoes were counted. 
Mosquito mortalities observed within experimental groups were adjusted for mortality 
that occurred in the corresponding control groups using Abbott’s formula [42]. Only 
experimental trial with control mortalities under 25% were used for further analysis. Log-probit 
analyses were conducted to estimate LC50 values (Minitab Inc., State College PA, USA). 
Mosquito survivorship was analyzed using a Kaplan-Meier survival analysis and Log-rank 
Mantel-Cox test (GraphPad Software, La Jolla, CA USA).  
Permethrin bottle bioassays.  Bioassay bottles were set up using the guidelines from the 
Centers of Disease Control and Prevention (CDC) [43]. Reference diagnostic dosages (the dose 
of insecticide needed to kill 100% of susceptible mosquitoes at a given time) for each mosquito 
genus were used to create 500 ml stock solutions of permethrin and absolute ethanol [43, 44]. 
The 250-ml glass bottles used for the bioassay were first washed in warm soapy water and rinsed 
thoroughly with clean water. They were left to dry completely. Before use, approximately ten 
mosquitoes were aspirated into a clean bottle to determine if the cleaning was adequate (no 
deaths within 15 minutes). Bottles and caps were labeled with their respective dosages, one 
control and two treatments. One ml of absolute ethanol only was added to control bottles. One ml 
of stock solution was added to each treatment bottle. To coat the bottle, the liquid was swirled to 
first coat the bottom, inverted to coat the cap, then rotated slowly to coat all the sides. Once 
coated, the caps were removed and the bottles were continuously rolled until the ethanol had 





aluminum foil to prevent light exposure until the experiment began. One control and two 
treatment bottles were used for each mosquito species.  
 Mosquitoes were aspirated into each bottle gently to avoid damage from hitting the glass. 
Approximately 20-40 mosquitoes were introduced into each bottle. Before the timer began, 
mortality at the beginning of the experiment was noted (Time 0). The experiment lasted for one 
hour, though the permethrin diagnostic time was at 30 minutes for each mosquito species. Every 
15 minutes, dead and/or alive mosquitoes were counted in each bottle.  As per CDC guidelines, 
mosquitoes were considered dead when they were immobile and could not stand [43]. At the end 
of the hour, bottles were placed into a -20C freezer to kill any remaining mosquitoes, and the 
total number of mosquitoes recorded.  
According to the World Health Organization and Centers for Disease Control, mortality 
in the control group may be ignored up to 10% mortality [43]. If any control bottles showed 
more than 10% mortality, that experiment was discarded and repeated with newly prepared 
bottles.  Mosquitoes surviving beyond the diagnostic time represented a proportion of 
mosquitoes that had some degree of resistance [43]. Data interpretation was based on World 
Health Organization recommendations for detecting resistance:  
• Susceptible: 98%-100% mortality at the diagnostic time. 
• Possible Resistance: 80%-97% mortality at the diagnostic time. 
• Resistance: <80% mortality at diagnostic time [45].  






In silico DNA sequence analyses for the glutamate-gated chloride channels.  Annotated 
GluCl coding sequences were obtained from the Eukaryotic Pathogen, Vector and Host 
Informatics Resources (VEuPathDB) [46]. These sequences were annotated based on the known 
GluCl sequence from Anopheles gambiae (mosquito), Caenorhabditis elegans (nematode), and 
Drosophila melanogaster (fruit fly) [47–49]. Each exon was then subjected to the Basic Local 
Alignment Search Tool (BLAST) through VEuPathDB (which uses NCBI BLAST) to find 
similar sequences. The resulting sequences were aligned using BioEdit Sequence Alignment 
Editor’s built in ClustalW function [50, 51]. To determine the best-fit nucleotide substitution 
model, jModelTest2 was used [52]. A general time reversable model (GTR) with a gamma 
distribution and invariant site rate (G+I) was chosen as the best fit. Since best fit model was 
GTR, a Randomized Axelerated Maximum Likelihood (RAxML) was used to construct the 
phylogeny of the aligned GluCl sequences along with a consensus tree with bootstrap replicates 
to calculate bootstrap values [53].  Bootstraps were considered significant if over 70% as this is 
considered a standard in evolutionary biology [54]. 
 Each exon was aligned individually, and individual exons were analyzed through 
Datamonkey [55] using the Branch-site Unrestricted Statistical Test for Episodic Diversification 
(BUSTED), an adaptive branch-site REL for episodic diversification (aBSREL), a fixed effects 
likelihood (FEL) and a mixed effects model of evolution (MEME). The BUSTED model 
estimated gene-wide episodic selection, where the rate of synonymous substitutions is less than 
the nonsynonymous substitution [56]. Potential selective pressures on the branches were 
identified using an aBSREL model [57].  A FEL model estimates nucleotide substitution rates 
site-by-site using a fixed ratio nonsynonymous and synonymous nucleotide substitutions and can 





analysis but proposes variation the ratio of nonsynonymous and synonymous substitution if there 
is positive selection occurring within the exons [59].  
Results 
Intrathoracic injections.  A total of 6 reps and 4 reps respectively (606 An. stephensi and 293 
An. albimanus) were used to determine the relative parenteral toxicities of inoculated ivermectin. 
Injected ivermectin was significantly more toxic to An. stephensi (3-day LC50=49 ng/ml) than to 
An. albimanus (3-day LC50=188 ng/ml) (Table 7.1, Figure 7.1). However, An. albimanus was 
more susceptible when injected with ivermectin (LC50=188 ng/ml, Figure 7.1) compared to 
when they ingested ivermectin (4-day LC50=1468 ng/ml, Figure 2.1). Conversely, An. stephensi 
was more susceptible to ivermectin when it was ingested (4-day LC50=7 ng/ml, Figure 2.1) than 
when ivermectin was injected (LC50=49 ng/ml, Figure 7.1). 
Permethrin bottle bioassay.  When exposed to permethrin, Ae. aegypti F39 had an average of 
87% mortality, compared to 0% mortality in the control group (Table 2). After 60 minutes post 
exposure, the mortality increased to an average of 96% (Table 2). The two replicates varied in 
their susceptibility to permethrin, with replicate 1 having 83% mortality and replicate 2 having 
91% mortality at the diagnostic time (Figure 7.2a). 
 Permethrin-exposed An. albimanus had an average of 97% mortality at the diagnostic 
time point, compared to the 0% mortality in the control group (Table 2). At 60 minutes post 
exposure, this mortality increased to 99% (Table 2b). While the two replicates varied in 
susceptibility, they were more consistent than the replicates of Ae. aegypti and Cx. pipiens, with 
100% and 94% susceptibility in the two An. albimanus replicates (Figure 7.2b).  
 When exposed to permethrin, An. stephensi had an average mortality of 98% at the 





increased to 100% mortality at 60 minutes post exposure. Like An. albimanus, the replicates 
were comparable in their susceptibility to permethrin (100% and 95% mortality, Figure 7.2c). 
 When exposed to permethrin, Cx pipiens, had an average mortality of 86% at the 
diagnostic time point (Table 2). This later increased to 96% mortality at 60 minutes post 
exposure (Table 2). There was noted variation between the two replicates, with 97% mortality 
and 75% mortality observed at the 30-minute diagnostic time point (Figure 7.2d).  
Glutamate-gated chloride channels.  A general phylogeny of the GluCl’s sequences and 
branch length values was constructed using RAxML (Figure 7.3). There were 102 bootstrap 
replicates which were then used to calculate and add the bootstrap values to the phylogeny 
(Figure 7.3). The Aedes clade was used to root the tree. All Aedes aegypti variant transcripts fell 
within a well-supported monophyletic clade, though the individual transcripts varied in support 
to one another (Figure 7.3). There was high support for the clade of An. albimanus and An. 
darlingi, belong to the subgenera Nyssorhynchus as well as high support for An. sinensis and An. 
atroparvus, in the subgenera Anopheles (Figure 7.3). The clade containing members of the 
Anopheles and Cellia subgenera was also well supported. There was high support for the clade 
containing the An. gambiae complex, but low support for the relationships within the clade 
(Figure 7.3) 
Seven exons from the An. albimanus GluCl sequence were identified and used in the 
BLAST. The gene-wide BUSTED analysis showed no evidence of diversifying selection in 
either internal branches or external nodes in exons 1 through 6. Only exon 7 showed gene-wide 
evidence of diversifying selection compared to the null model (Likelihood ratio test: p<0.0001, 
Table 7.2). The MEME and FEL models identified the same two sites (2 and 4) on exon 7 





exons 1 through 6 (excluding exon 3, which had no evidence of purifying or diversifying 
selection) had multiple sites undergoing significant purifying selection (Tables 7.5-7.10). The 
aBSREL analysis showed no diversifying selection within the branches of the tree.  
Discussion 
Intrathoracic injections.  The rationale for injecting ivermectin is that the target molecules for 
ivermectin (the GluCls) reside within nervous and muscle tissue outside of the midgut [22, 24]. 
Injection bypasses the midgut and when injected directly into the hemocoel of An. albimanus, 
ivermectin not only worked more rapidly but was also 10-fold more toxic than when it was 
ingested in a blood meal. This indicates that ingested ivermectin was poorly absorbed across the 
gut of An. albimanus. Even so, injected ivermectin was still significantly less toxic to An. 
albimanus (LC50=188 ng/ml) than to An. stephensi (LC50=49 ng/ml), suggesting that the 
binding affinity of ivermectin and/or its stimulatory effect on the GluCls of An. albimanus was 
less than that of the GluCls of An. stephensi.  
 As an aside, it should be noted ivermectin was significantly more toxic to An. stephensi 
when ingested (LC50=7 ng/ml) than when injected (LC50=49 ng/ml). This suggests that 
ivermectin metabolites resulting from digestion of blood may contribute to the overall oral 
toxicity of ivermectin to An. stephensi. While ivermectin remains largely unchanged during 
metabolism and excretion, several metabolites have been identified in mammals, usually present 
several weeks after ivermectin treatment [60, 61, 80]. The role of metabolites in mosquito 
mortality were discussed in Kobylinski et al. [79] when comparing An. minimus and An. dirus 
feeding on ivermectin-treated blood from membrane feeders versus feeding on ivermectin-
treated humans. There was a significant delay in mortality and a substantial increase in mortality 





This corresponds with the time needed to pass through the midgut and begin metabolizing, as 
well as demonstrates the role ivermectin metabolites may play in its lethality. In our own mice 
studies, we saw substantial mortality in An. albimanus one day after ivermectin treatment, even 
though they have an incredible tolerance to ivermectin (Chapter 2; LC50:1468 ng/ml). From the 
literature the maximum plasma concentration in mice treated with ivermectin in their water (32 
mg/L) was 90 ng/ml, almost 16 times less than the LC50 found during membrane feeds, yet there 
was still significant mortality, possibly from ivermectin metabolites [81].  
Permethrin bottle bioassay.  An. stephensi was the most susceptible to permethrin, followed 
closely by An. albimanus.  Conversely, Cx. pipiens and Ae. aegypti were markedly more resistant 
to permethrin than the Anopheles. All species had nearly 100% mortality after 1 hour of exposure 
to permethrin. The An. albimanus colony may be starting to develop permethrin resistance (as 
per the WHO specifications), but it is at a very early stage. The Cx. pipiens and Ae. aegypti were 
also in the “possible resistance” category as they had a much lower diagnostic time mortality rate 
than either Anopheles species.  
Since An. albimanus STECLA exhibited little resistance to permethrin, it seems likely the 
cytochrome P450 system is not the mechanism of ivermectin tolerance. Wild An. albimanus have 
demonstrated pyrethroid and DDT resistance in the past [17, 62–64]. However, An. albimanus 
STECLA have been in colony for more than 40 years. While considered a wild-type strain, any 
mosquito maintained in laboratory conditions for over hundreds of generations will almost 
certainly begin to display different behavioral or physiological reactions. For example, while 
many strains and wild-caught An. albimanus displayed avoidance behaviors to DDT and 





with colony mosquitoes and wild-caught specimens, the wild-caught mosquitoes behave and feed 
much differently than colony mosquitoes.  
While permethrin resistance in An. stephensi has been documented in the wild [66], the 
UND Biology strain of An. stephensi STE2 are not resistant to permethrin. Interestingly, the 
UND Biology strain of An. stephensi STE2 is also the most ivermectin-susceptible species of 
Anopheles tested to date [Table 2.1]. 
 Aedes aegypti had higher survival at the diagnostic time compared to An. stephensi or An. 
albimanus. Resistance to permethrin is an issue in Ae. aegypti and the closely related Ae. 
albopictus worldwide [13, 44, 68]. Aedes are more resistant to ivermectin as well. In a study 
examining seven strains of Aedes aegypti, including permethrin resistant strains, ivermectin 
LC50s ranged from approximately 180 ng/ml to 580 ng/ml [20]. These LC50s were much higher 
than most species of Anopheles treated with ivermectin [67]. Interestingly, the same strains of 
Ae. aegypti that were permethrin resistant were also more tolerant of ivermectin, clearly linking 
the detoxification mechanisms in this species.   
Culex pipiens had the lowest mortality at the diagnostic time and was the most resistant 
to permethrin of the species tested. This is consistent with other research documenting 
worldwide permethrin and pyrethroid resistance in the Cx. pipiens species complex [18, 44, 69–
71]. The permethrin resistance in the Cx. pipiens species complex is directly related to 
overexpression and mutations in the P450 gene family [12, 18, 69, 71]. Generally, Culex 
mosquitoes are also more resistant to ivermectin compared to Anopheles. In one early 
experiment, ivermectin was effective against Cx. quinquefasciatus at the higher dosages when 
the mosquitoes fed on cotton impregnated with ivermectin in sucrose [72]. The mortality after 24 





treated mice, the mortality at 36 hours post feed in Cx. quinquefasciatus was approximately 50% 
while An. stephensi had 100% mortality at the same time point [72]. An experiment using Cx. 
salinarus showed no difference in the mosquitoes that fed on dogs treated with a range of 
ivermectin dosages versus the control mosquitoes [73]. Finally, when Cx. quinquefasciatus were 
fed on ivermectin treated humans, there was no difference in survival compared to the control 
group, while the An. gambiae mosquitoes fed on the treated humans had a significantly lower 
survival rate compared to their control counterparts [74].  
Glutamate-gated chloride channel sequence analysis.  A phylogeny was constructed using 21 
different species of mosquitoes: 19 species of Anopheles and two species of Aedes. While higher 
branch support is desired, the analysis was only performed with one gene, while more robust 
phylogenies will use multiple genes or morphological characteristics. Running the bootstrapping 
analysis for more iterations could also produce higher statistical support. Nonetheless, there were 
numerous consistencies with known genome assemblies of Anopheles and their subgenera [75–
78]. There was strong support for the evolutionary divergence of the subgenus Nyssorhynchus 
from the subgenera Cellia and Anopheles. The divergence of the subgenera Anopheles and Cellia 
from one another was also well supported. Excluding An. funestus, all African Anopheles species 
fell into one monophyletic clade, while Anopheles species in Asia had some members (An. 
epiroticus and An. sinensis) outside of their clade. Within the African Anopheles species, there 
was high support for the clade representing the members of the An. gambiae complex. As 
expected, the two members of Nyssorhynchus that were included in the analysis (An. albimanus 
and An. darlingi) were closely related. This analysis showed that the An. albimanus STECLA 
GluCl sequence was nearly identical to An. darlingi. The phylogeny alone shows no significant 





 The GluCl gene is highly conserved throughout the species tested. Most analyses 
(BUSTED, aBSREL, and MEME) only identified instances of positive selection. The aBSREL 
analysis showed no positive selection. A BUSTED analysis showed no gene wide diversifying 
selection in any exons except exon eight. Similarly, MEME detected sites of positive selection 
on only on exon eight. The FEL analysis which tests for both positive and negative selection, 
showed widespread negative selection on almost all exons, except exon eight. The GluCls are 
essential for several functions including locomotion, feeding, and sensory input [22]. As GluCls 
are responsible for crucial neuronal and muscular functions, it makes sense there would be strong 
negative selection against mutation of this gene. While there are mutations that confer 
ivermectin-resistance, most mutations in this essential gene are likely selected against [22, 24, 
40]. 
 The exception was exon 7, which showed a high degree of positive selection. The 
positive selection occurring gene-wide and at individual sites were substantial and may be the 
link to the extreme tolerance to ivermectin seen in An. albimanus STECLA. Though this analysis 
revealed no firm indicators of resistance, other genes may be involved that either influence the 
GluCls resistance or are directly a target of ivermectin, but resistant themselves. There could also 
be post-translational modifications that change how the protein is expressed and how ivermectin 
binds.  
The results of these three experiments reveal telling information about the ivermectin 
tolerance of An. albimanus STECLA. First, passage through the midgut is inhibited, meaning 
ivermectin cannot reach the GluCls in the hemocoel. This should be further investigated along 
with how ivermectin is metabolized in mosquitoes. Profusion and assays should be used at 





through mosquitoes Second, there was no evidence that upregulation or changes in the 
expression of cytochrome P450 causes ivermectin tolerance in this strain, as they displayed no 
permethrin resistance. Finally, mutations on the GluCl gene are highly selected against across 
most of the gene. However, exon 7 displays positive selection. While intriguing, more research 
using protein expression studies in An. albimanus STECLA are needed to determine how the 
changes in this exon are affecting the gene and its protein production. As of now midgut 
impermeability is the only explanation that can be confirmed as a mechanism for ivermectin 
resistance in An. albimanus STECLA, but further research needed as it not only can explain 
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Figure 7.1 Daily proportion of surviving mosquitoes after injection of ivermectin at various 







Table 7.1. Percent mortality during a permethrin bottle bioassay at the diagnostic time point (30 
minutes for each species) and at 60 minutes post exposure (the experiment end) 
Species Strain Dosage (ug/bottle) 
Average % mortality 
at the diagnostic 
time* 
Average % mortality at 
60 minutes post 
exposure 
Aedes aegypti F39 
0 0% 0% 
15 87% 96% 
Anopheles albimanus STECLA 
0 0% 0% 
21.5 97% 99% 
Anopheles stephensi STE2 
0 0% 0% 
21.5 98% 100% 
Culex pipiens CPCO 
0 0% 0% 
























































Figure 7.2. Proportion of different mosquito species surviving one hour of sustained permethrin 
exposure during a bottle bioassay. Red line indicates each species’ diagnostic time as per CDC 
















































Figure 7.3. Phylogenic tree constructed from the glutamate-gated chloride channel sequences of several mosquito species. Names in 
parentheses indicate mosquito strain from which each sequence was derived (only first Ae. Aegypti strain labeled with strain name; all 





Table 7.2. BUSTED model of significant diversifying selection on the GluCl gene EXON 7 in 
Aedes and Anopheles. Constrained model indicates null model, with no selection allowed ω3. 
Unconstrained model indicates experimental model allowing selection on ω3.  
Model logL Parameters AICc CV(SRV)* ω1 ω2 ω3 
Unconstrained -426.3 59 981.3 11.9 1.0 1.0 37.1 
Constrained -443.7 58 1013.7 0.68 0.92 0.92 1.00 
*CV(SRV): Coefficient of variation in synonymous substitution rates 
 
 
Table 7.3. MEME model showing significant diversifying selection at two sites on the GluCl 
gene EXON 7 in Aedes and Anopheles (38 sites tested in total) 
Site P+ Likelihood ratio p-value 
Type of 
selection 
2 1.00 5.61 0.03 positive 
4 1.00 5.27 0.03 positive 




Table 7.4. Sites with significant selection as determined by a FEL analysis of the GluCl gene 
EXON 7 in Aedes and Anopheles exon 7 (38 sites total).  





2 23.204 4.691 0.03 0.724 positive 
4 23.692 5.049 0.025 0.827 positive 
21 85.178 4.662 0.031 1.334 positive 
*Total branch length: used to scale the alpha=beta, based on contributing interference of the 





Table 7.5. Sites with significant selection as determined by a FEL analysis of the GluCl gene 
EXON 7 in Aedes and Anopheles (20 sites total).  





5 0.376 4.717 0.030 1.669 negative 
15 0.335 4.123 0.042 0.757 negative 
16 0.884 12.290 <0.0001 1.537 negative 
18 1.254 8.729 0.003 3.863 negative 
*Total branch length: used to scale the alpha=beta, based on contributing interference of the 




Table 7.6. Sites with significant selection as determined by a FEL analysis of the GluCl gene 
EXON 2 in Aedes and Anopheles (35 sites total).  





2 0.230 5.55 0.018 0.81 negative 
8 0.492 4.87 0.027 1.805 negative 
15 399.78 6.26 0.012 299.655 negative 
23 15.336 5.18 0.023 11.865 negative 
24 0.181 4.29 0.038 1.29 negative 
26 1.16 4.61 0.032 1.627 negative 
31 0.130 5.08 0.024 4.143 negative 
32 1.838 4.23 0.040 3.992 negative 
*Total branch length: used to scale the alpha=beta, based on contributing interference of the 






Table 7.7. Sites with significant selection as determined by a FEL analysis of the GluCl gene 
EXON 4.1 in Aedes and Anopheles (30 sites total).  





5 0.268 3.81 0.051 0.364 negative 
8 0.60 8.49 0.004 0.933 negative 
9 0.213 5.59 0.018 0.527 negative 
12 0.391 6.89 0.009 0.712 negative 
13 0.186 7.68 0.006 0.388 negative 
14 0.086 5.27 0.022 1.083 negative 
15 0.599 5.80 0.016 0.579 negative 
16 0.685 12.08 0.001 1.546 negative 
17 0.576 6.68 0.01 0.540 negative 
18 0.410 7.56 0.006 0.648 negative 
19 0.686 10.51 0.001 1.071 negative 
20 0.495 5.54 0.019 0.611 negative 
21 0.613 6.97 0.008 0.555 negative 
22 0.425 10.53 0.001 1.009 negative 
24 0.386 3.99 0.046 0.447 negative 
25 0.366 5.21 0.022 0.522 negative 
26 0.156 5.84 0.016 0.403 negative 
27 0.430 17.43 <0.0001 1.666 negative 
29 0.637 9.14 0.002 0.798 negative 
30 0.511 20.43 <0.0001 1.893 negative 
*Total branch length: used to scale the alpha=beta, based on contributing interference of the 






Table 7.8. Sites with significant selection as determined by a FEL analysis of the GluCl gene 
EXON 4.2 in Aedes and Anopheles (48 sites total).  





2 1.343 17.110 <0.0001 2.753 negative 
3 0.543 8.589 0.003 0.987 negative 
5 0.299 4.431 0.035 0.439 negative 
6 0.482 6.560 0.010 0.782 negative 
9 0.493 10.543 0.001 3.125 negative 
10 0.841 9.432 0.002 0.925 negative 
11 0.340 3.913 0.048 0.439 negative 
12 0.510 4.469 0.035 0.374 negative 
15 0.699 9.026 0.003 1.198 negative 
16 0.486 6.653 0.010 0.816 negative 
18 0.290 4.266 0.039 0.418 negative 
19 0.350 6.132 0.013 0.780 negative 
22 1.094 19.571 <0.0001 10.271 negative 
27 0.314 3.960 0.047 0.427 negative 
28 0.405 4.487 0.034 0.414 negative 
29 0.631 5.548 0.019 0.530 negative 
31 0.718 12.972 <0.0001 1.775 negative 
32 0.497 6.174 0.013 0.670 negative 
33 0.462 10.518 0.001 2.675 negative 
34 1.237 12.658 <0.0001 1.831 negative 
35 1.034 12.861 <0.0001 1.707 negative 
39 0.482 8.965 0.003 1.210 negative 
40 0.498 6.082 0.014 0.607 negative 
41 0.501 5.805 0.016 0.527 negative 
44 0.731 7.845 0.005 1.204 negative 
45 0.307 3.924 0.048 0.394 negative 
*Total branch length: used to scale the alpha=beta, based on contributing interference of the 





Table 7.9. Sites with significant selection as determined by a FEL analysis of the GluCl gene 
EXON 5 in Aedes and Anopheles (35 sites total).  





3 0.470 3.830 0.05 0.364 negative 
8 0.395 4.785 0.029 0.403 negative 
9 0.549 6.796 0.009 0.928 negative 
10 0.558 6.305 0.012 1.012 negative 
11 0.672 6.431 0.011 0.781 negative 
12 0.725 7.814 0.005 0.725 negative 
14 0.322 5.179 0.023 0.651 negative 
19 2.156 23.988 <0.0001 11.007 negative 
20 0.557 5.351 0.021 0.766 negative 
21 1.023 7.712 0.005 1.078 negative 
22 0.386 10.611 0.001 1.251 negative 
23 0.465 7.409 0.006 0.565 negative 
25 0.292 4.516 0.034 0.415 negative 
29 0.298 6.196 0.013 0.417 negative 
33 0.260 12.349 <0.0001 0.737 negative 
*Total branch length: used to scale the alpha=beta, based on contributing interference of the 






Table 7.10. Sites with significant selection as determined by a FEL analysis of the GluCl gene 
EXON 6 in Aedes and Anopheles (31 sites analyzed).  





1 0.383 4.689 0.03 0.296 negative 
2 0.639 5.578 0.018 0.424 negative 
3 0.430 4.758 0.029 0.283 negative 
4 0.482 5.662 0.017 0.437 negative 
6 0.753 7.758 0.005 0.408 negative 
7 0.651 5.114 0.024 0.425 negative 
9 0.308 7.300 0.007 0.876 negative 
10 0.730 9.241 0.002 1.458 negative 
12 0.383 7.682 0.006 1.447 negative 
16 0.386 3.890 0.049 0.317 negative 
17 0.379 5.228 0.022 0.574 negative 
19 0.856 7.670 0.006 0.591 negative 
24 0.311 5.204 0.023 0.315 negative 
27 0.939 4.732 0.030 0.921 negative 
30 0.429 4.101 0.043 0.312 negative 
*Total branch length: used to scale the alpha=beta, based on contributing interference of the 
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CONCLUSIONS AND FUTURE DIRECTIONS 
 This research examined seven compounds currently used in the veterinary industry as 
systemic parasiticides for companion animals and livestock. The compounds were tested for their 
effectiveness against two species of Anopheles mosquitoes that are major malaria vectors and 
known to feed on livestock in nature. Compounds were administered to mosquitoes using both in 
vitro (membrane feeds) and in vivo (cattle and mice) feeding techniques and post-feeding 
mortality and reproductive development was compared. In general, systemic parasiticides were 
effective against both Anopheles albimanus and An. stephensi mosquitoes. However, different 
compounds varied in their effectiveness depending on the species and strain of the mosquito. 
Anopheles albimanus STECLA, a laboratory strain that has been in colony for several decades 
was nearly impervious to the four macrocyclic lactones tested, including ivermectin. Conversely, 
An. stephensi STE2 (another long-established laboratory strain) and wild-populations An. 
albimanus were highly susceptible to ivermectin. Fipronil, a phenylpyrazole compound, was 
extremely effective against both An. albimanus STECLA and wild strains of An. albimanus but 
was significantly less effective against An. stephensi STE2. The two isoxazolines compounds 
were moderately effective against both species. At sublethal doses, several drugs (ivermectin, 
fipronil, and afoxolaner) reduced the reproductive potential of mosquitoes by inhibiting blood 






 In both mice and cattle, ivermectin and fipronil reduced survival in An. stephensi and 
wild-caught An. albimanus, but ivermectin’s effectiveness only lasted a week, while fipronil 
lasted at least two weeks. Also, when ivermectin was topically applied, it was effective 
throughout the body, not just at the site of application, exactly like injected ivermectin. However, 
after three weeks, lethality waned in mosquitoes fed on calves treated with injected ivermectin. 
Topical ivermectin was still lethal to mosquitoes, but only around the application site. 
Mosquitoes fed on calves treated with topical ivermectin also had a reduced feeding rate 
compared to those fed on untreated calves or calves treated with injectable ivermectin. This 
topical ivermectin repellency was most prominent 2 days post treatment, and lessened (but did 
not completely disappear) as the experiment progressed. Like in the in vitro membrane feeds, 
mosquitoes feeding on ivermectin or fipronil treated cattle had decreased reproductive potential.  
 Since An. albimanus STECLA was incredibly tolerant to ingested ivermectin, we 
explored three tolerance hypotheses. The first hypothesis was ivermectin is not absorbed through 
the midgut to affect the nervous system. I confirmed that there was an absorption barrier by 
conducting parenteral injection, which bypassed digestion and allowed ivermectin to directly 
interact with its target, the glutamate-gated chloride channels. While their injected LC50 was 
much lower than their ingested LC50, An. albimanus STECLA still had a much higher LC50 
compared to other Anopheles. Other mechanisms must be at work to increase tolerance to 
ivermectin. I hypothesized this could be due to increased levels or efficiency of the enzyme 
cytochrome P450 (responsible for breaking down ivermectin) or conformation changes in 
ivermectin’s target receptor, the glutamate-gated chloride channels (GluCls). To test cytochrome 





insecticide that is also metabolized by cytochrome P450. By testing An. albimanus reaction to 
permethrin, I determined An. albimanus STECLA did not have permethrin resistance.  Therefore, 
cytochrome P450 is not the mechanism for ivermectin tolerance Finally, I looked at the 
phylogeny of the glutamate-gated chloride channels (GluCl) the target of the ivermectin 
molecule. If significant positive selection was occurring, it may indicate An. albimanus STECLA 
has mutations in its GluCl, causing ivermectin to not bind to the receptor and function. We 
constructed a phylogeny of several mosquito species, predominantly Anopheles, as well as 
analyzed each exon for selection. We found one exon undergoing positive selection, while the 
others were highly conserved. This positive selection may be responsible for An. albimanus 
STECLA ivermectin tolerance, but this cannot be confirmed. To further delve into the resistance 
of An. albimanus STECLA. A more robust analysis of An. albimanus STECLA genes and a 
protein expression would be the next step in determining if mutations in the GluCl are 
responsible for ivermectin resistance. 
 In conclusion, these in vitro and in vivo pilot studies are the first step in implementing 
vector control through systemic insecticide livestock treatment in Central America. The next step 
is to conduct a larger field study, with multiple farms. Examining the ages of wild-caught An. 
albimanus before and after nearby herds of cattle will help determine if the compound(s) affect 
the mosquito’s population structure. This study also highlights the necessity of testing many 
Anopheles species, as different species and strains have different tolerances to ivermectin, and 
vector control using systemic parasiticides can be tailored to the regional vectors. Finally, 
monitoring areas undergoing vector control using systemic veterinary insecticides. is essential to 





rotating basis, or strict timing of seasonal applications of drugs can mitigate resistance and 
should be considered when implementing vector control in a region.  
